NIH Clinical Research Studies Listed By Protocol Number

Active Accrual, Protocols Recruiting New Patients 
* 09-NR-0131:
Fatigue in Healthy Individuals

* 09-NR-0088:
Molecular-Genetic Correlates of Fatigue in Cancer Patients Receiving Localized External Beam Radiation Therapy

* 09-NR-0064:
Brain-Gut Interactions in Overweight and Normal Weight Patients with Chronic Abdominal Pain

* 09-N-0197:
Double Blind Placebo-Controlled Phase I/II Clinical Trial of Idebenone in Patients with Primary Progressive Multiple Sclerosis

* 09-N-0196:
High-Density Direct Current Brain Polarization

* 09-N-0193:
A Study of Acetyl Hexapeptide-8 (AH8) in Treatment of Blepharospasm

* 09-N-0160:
Convection Enhanced Delivery of Muscimol to Study the Pathophysiology Underlying the Clinical Features of Parkinson's Disease

* 09-N-0146:
Changes in the Posterior Parietal Cortex - Primary Motor Cortex Pathway Induced by Motor Training

* 09-N-0125:
Magnetoencephalography in Absence Seizures

* 09-N-0124:
Effects of Reward on Learning in the Motor Cortex

* 09-N-0118:
Investigation of Neurofeedback with Real-Time fMRI in Healthy Volunteers and Patients with Hyperkinetic Movement Disorders

* 09-N-0114:
Droxidopa for Neurogenic Orthostatic Hypotension

* 09-N-0098:
Exploring a Motor Learning Technique Based on the Mirror Motor Neuron System

* 09-N-0084:
Double-Blind, Placebo Controlled Pilot-Study of Octanoic Acid in Essential Tremor

* 09-N-0032:
Comprehensive Multimodal Analysis of Patients with Neuroimmunological Diseases of the CNS

* 09-N-0021:
Enhancing the Beneficial Effects of Upper Extremity Visuomotor Training with tDCS

* 09-N-0010:
Biomarkers of Risk of Parkinson Disease

* 09-M-0198:
Screening and Evaluation of Patients with Signs and Symptoms of Alzheimer's Disease

* 09-M-0182:
GABA/Glutamate Balance in Temporal Lobe Epilepsy With and Without Major Depression

* 09-M-0177:
CO2 Inhalation and Risk for Panic Disorder

* 09-M-0176:
Functional Relevance of Dopamine Receptors in Healthy Controls and Patients with Schizophrenia: Characterization through [11C]NNC-112 and [18F]Fallypride Positron Emission Tomography

* 09-M-0171:
Identification of Characteristics Associated with Symptom Remission in Autism

* 09-M-0123:
Regional Rates of Cerebral Protein Synthesis: Effects of Sleep and Memory Consolidation

* 09-M-0042:
Double-Blind Placebo-Controlled Trial of Riluzole in Pediatric Bipolar Disorder

* 09-M-0040:
Imaging Cannabinoid CB1 Receptors in Alcohol Dependence

* 09-M-0034:
A Controlled Trial of Serotonin Reuptake Inhibitors Added to Stimulant Medication in Youth with Severe Mood Dysregulation

* 09-M-0022:
The Use of a Distress Thermometer in a Pediatric Research Setting: An Exploratory, Pilot Study

* 09-I-0204:
VRC 308: An Open-Label Phase I Study of the Safety and Immunogenicity of an Investigational H1 DNA Influenza Vaccine, VRC-FLUDNA057-00-VP, in Healthy Adults 18-70 Years Old

* 09-I-0184:
Studies in the Pathogenesis of Systemic Capillary Leak Syndrome

* 09-I-0175:
A Multicenter, R-D/B-P/C, Parallel-Group Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Two Single IV Infusions of AIN457 10 mg/kg (Anti IL-17 Monoclonal Antibody) in Patients W/Moderate to Severe Active Crohn's Disease

* 09-I-0172:
Natural History of Bronchiectasis

* 09-I-0170:
Immune Responses to Varicella-Zoster Virus Vaccination and Infection

* 09-I-0163:
HVTN 505: Ph 2 RPCT to Eval Safety/Effect Post-HIV Acquisition Viremia of Multiclade HIV-1 DNA Plasmid Vaccine F/B Multiclade HIV-1 Recombinant Adenoviral Vector Vaccine in HIV-Uninfected, Adenovirus Type 5 Neutralizing AB Negative, Circumcised Men

* 09-I-0157:
Host Factors in Invasive and Recurrent Staphylococcus Aureus Infection

* 09-I-0133:
Establishing Fibroblast-derived Cell Lines from Skin Biopsies of Patients with Immunodeficiency or Immunodysregulation Disorders

* 09-I-0129:
A Randomized Double-Blinded, Placebo-Controlled Study of Omalizumab for Idiopathic Anaphylaxis

* 09-I-0126:
Pathogenesis of Physical Induced Urticarial Syndromes

* 09-I-0108:
Strategic Timing of AntiRetroviral Treatment (START)

* 09-I-0102:
Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ Lymphocytopenia

* 09-I-0090:
VRC 307: A D/B Randomized Ph. I Study of Safety/Immunogenicity of a Prime-Boost Schedule of an Investigational DNA Influenza Vaccine, Followed by the Seasonal Influenza Trivalent Inactivated Vaccine (TIV), Compared to TIV Alone in Healthy Adults

* 09-I-0086:
Screening Protocol for Genetic Diseases of Mast Cell Homeostasis and Activation

* 09-I-0069:
Interleukin-7 (CYT107) Treatment of Idiopathic CD4 Lymphocytopenia: Expansion of CD4 T Cells (ICICLE)

* 09-I-0049:
Normal Blood, Bone Marrow and Buccal Mucosa Protocol

* 09-I-0030:
Clinical and Immunologic Monitoring of Patients with Known or Suspected HIV Infection

* 09-I-0013:
Biomarkers of Inflammation, Coagulation, and Endothelial Function in HIV-Infected Adults

* 09-I-0012:
An Open-Label, Randomized Phase I Study in Healthy Adults of 4 Prime-Boost Schedules with Monovalent Influenza Subunit Virion (H5N1) Vaccine (Sanofi Pasteur, Inc), Administered Alone or Following Recombinant DNA Plasmid (H5) Vaccine (VRC, NIAID)

* 09-HG-0128:
Leukodystrophies of Unknown Cause

* 09-HG-0035:
Clinical, Cellular, and Molecular Investigation into Oculocutaneous Albinism

* 09-HG-0009:
Participant Reactions to Disease Risk Information

* 09-H-0199:
A Pilot Study of a Thrombapoietin-Receptor Agonist (TPO-R agonist), Eltrombopag, in Patients with Low to Int-2 Risk Myelodysplastic Syndrome (MDS)

* 09-H-0183:
Horse ATG/CsA in Aplastic Anemia Patients Unresponsive to or with a Suboptimal Response to Rabbit ATG/CsA Treatment

* 09-H-0166:
Evaluation of Outcomes Following Mitral Valve Repair/Replacement in Severe Chronic Ischemic Mitral Regurgitation

* 09-H-0164:
Comparison of Cardiac Computed Tomography and Vasodilator Stress Magnetic Resonance Imaging Perfusion in Patients with Prior Equivocal Stress Test for Detection of Coronary Artery Disease

* 09-H-0154:
A Pilot Study of a Thrombopoietin-Receptor Agonist (TPO-R Agonist), Eltrombopag, in Aplastic Anemia Patients with Immunosuppressive-Therapy Refractory Thrombocytopenia

* 09-H-0094:
A Pilot Study of the Safety and Activity of Escalating Doses of ON 01910.Na in Patients with Relapsed Mantle Cell Lymphoma, Multiple Myeloma, Chronic Lymphocytic Leukemia, and Related Lymphoid Malignancies

* 09-H-0087:
Mismatched Donor Lymphocyte Infusions for Relapsed Disease Following Allogeneic Stem Cell Transplantation

* 09-H-0068:
Pilot Study of Mitochondrial Biology in Human Platelets

* 09-H-0062:
Collection of Blood and Bone Marrow Samples from Select Patients with CML to Measure Minimal Residual Disease

* 09-H-0050:
Surgical Interventions for Moderate Ischemic Mitral Regurgitation

* 09-EI-0191:
The Treatment of Uveitic Cystoid Macular Edema with Topical Interferon Gamma

* 09-EI-0116:
Subconjunctival Sirolimus for the Treatment of Autoimmune Active Anterior Uveitis

* 09-EI-0075:
Pilot Study for the Evaluation of Finasteride in the Treatment of Chronic Central Serous Chorioretinopathy

* 09-EI-0008:
Pilot Study of the Evaluation of Subconjunctival Sirolimus in the Treatment of Bilateral Geographic Atrophy Associated with Age-Related Macular Degeneration

* 09-DK-0140:
Natural History of Autoimmune Diabetes and Its Complications

* 09-DK-0097:
Vitamin E Pharmacokinetics and Biomarkers in Normal and Obese Women

* 09-DK-0081:
Selective Reduction of Dietary Carbohydrate Versus Fat: Effects on Metabolism, Endocrine Physiology, Brain Activity and Reward Circuitry

* 09-DK-0067:
Long-Term Follow-Up of HALT-C Sustained Virologic Responders

* 09-DK-0058:
Pharmacogenomic Response to Thyrotropin-Releasing Hormone Stimulation in Healthy Volunteers: The Influence of a Common Type 2 Deiodinase Genetic Polymorphism on Serum T3

* 09-DK-0056:
Novel Therapy Combining Regenerative Stimuli Immunomodulation to Preserve Beta Cell Function in New Onset Type 1 Diabetes

* 09-DK-0055:
Assessment of the Effects of a DPP-4 Inhibitor (Sitagliptin) Januvia on Immune Function in Healthy Individuals

* 09-DC-0002:
Studies of Measures of Attention

* 09-DA-0188:
Cocaine Dependence, Metabotropic Glutamate Receptor Subtype 5 (mGluR5) Density, Genetics and Craving (T-DA-0222)

* 09-D-0039:
A Phase I Study of the Intrathecal Administration of Resiniferatoxin for Treating Severe Refractory Pain Associated with Advanced Cancer

* 09-CH-0180:
Non-Invasive Non-Ionizing Polarized Imaging System to Assess Structure of Cervix

* 09-CH-0085:
Global Study of Women's Health

* 09-CH-0063:
Pilot Study of MRI-Guided High Intensity Focused Ultrasound Ablation of Uterine Fibroids

* 09-CH-0059:
Molecular Bases of Response to Copper Treatment in Menkes Disease, Related Phenotypes, and Unexplained Copper Deficiency

* 09-CC-0186:
Drug Interaction Study between Inhaled Beclomethasone and Protease Inhibitors in Healthy Volunteers

* 09-CC-0135:
Probiotic Ingestion and Isoagglutinin Titers

* 09-C-0212:
Multicenter Phase II Study of IMC-A12 in Patients with Thymoma and Thymic Carcinoma who have been Previously Treated with Chemotherapy

* 09-C-0195:
A Phase 2 Trial of Bevacizumab, Lenalidomide, Docetaxel, and Prednisone (ART-P) for Treatment of Metastatic Castrate-Resistant Prostate Cancer

* 09-C-0192:
Phase II Study of Cediranib (AZD2171) in Patients With Alveolar Soft Part Sarcoma

* 09-C-0189:
Prospective Randomized Trial Comparing Gastrectomy, Metastasectomy Plus Systemic Therapy Versus Systemic Therapy Alone: GYMSSA Trial

* 09-C-0174:
M06-822: A Phase 1/2a Study Evaluating the Safety, Pharmacokinetics, and Efficacy of ABT-263 in Subjects with Small Cell Lung Cancer or Other Non-Hematological Malignancies

* 09-C-0173:
A Phase I Study of Belinostat in Combination with Cisplatin and Etoposide in Adults with Small Cell Lung Carcinoma and Other Advanced Cancers

* 09-C-0168:
A Phase 1, Open-Label Study of MEDI-547 to Evaluate the Safety, Tolerability, Pharmacokinetics, and Biologic Activity of Intravenous Administration in Subjects with Relapsed or Refractory Solid Tumors Associated with EphA2 Expression

* 09-C-0161:
Follow Up Protocol for Subjects Previously Enrolled in NCI Surgery Branch Studies

* 09-C-0139:
A Pilot Study of Vaccination with Epitope-Enhanced TARP Peptide and TARP Peptide-Pulsed Dendritic Cells in the Treatment of Stage D0 Prostate Cancer

* 09-C-0138:
A Broad Multi-Histology Phase II Study of the Multi-Kinase Inhibitor R935788 (Fostamatinib Disodium) in Advanced Colorectal, Non-Small Cell Lung, Head and Neck, Hepatocelluar and Renal Cell Carcinomas and Pheochromocytoma and Thyroid Tumors

* 09-C-0130:
Pilot Study of Liposomal Doxorubicin Combined with Bevacizumab Followed by Bevacizumab Monotherapy in Adults with Advanced Kaposi's Sarcoma

* 09-C-0127:
Evaluation of Late Treatment Effects in Long-Term Survivors of Hodgkin's Disease Previously Treated at NIH: A Multi- Institutional Trial

* 09-C-0120:
An Exploratory Evaluation of Biomarkers in Blister Fluid in Healthy Volunteers and Irradiated Skin

* 09-C-0119:
A Phase 1 Trial of AVN944, an IMPDH Inhibitor, in Adults with Advanced Stage Solid Tumors

* 09-C-0113:
A Pilot Study to Explore Serum and Imaging Biomarkers in Patients with Spinal Cord Compression

* 09-C-0112:
A Phase I Study of MK-0752 in Pediatric Patients with Recurrent or Refractory CNS Malignancies

* 09-C-0111:
A Phase 1, Dose Escalation Study of the Safety, Tolerability and Pharmacokinetics of Intravenous Dimethane Sulfonate (DMS612, NSC 281612 in Advanced Malignancies

* 09-C-0109:
Early Molecular Detection for the Improved Diagnosis of Invasive Pulmonary Aspergillosis and Invasive Pulmonary Zygomycosis

* 09-C-0107:
Phase II Study of Neoadjuvant Gemcitabine, Cisplatin and Bevacizumab in Stage IIIA (N2), Non-Squamous Cell Non-Small Cell Lung Cancer

* 09-C-0104:
A Randomized, Double-Blinded, Placebo-Controlled, Multi-Institutional, Phase II.5 Study of AZDO53O, a Selective Src Kinase Inhibitor, in Patients with Recurrent Osteosarcoma Localized to the Lung

* 09-C-0103:
Prospective Analysis of Genotypes in Adults Undergoing Therapy for Lung Cancer

* 09-C-0101:
Open Label Phase I Study to Evaluate the Safety and Tolerability of Vaccine (GI-6207) Consisting of Whole, Heat-Killed Recombinant Saccharomyces Cerevisiae Genetically Modified to Express CEA Protein in Adults with Metastatic CEA-Expressing Carcinoma

* 09-C-0100:
A Natural History Study of Patients Receiving High Dose Rate Brachytherapy

* 09-C-0096:
Pilot and Feasibility Study of Reduced-Intensity Hematopoietic Stem Cell Transplant for MonoMAC

* 09-C-0092:
Phase 1/2 Study of Metastatic Renal Cancer using T-Cells Transduced with a T-Cell Receptor which Recognizes TRAIL Bound to the DR4 Receptor

* 09-C-0089:
A Targeted Phase I/II Trial of ZD6474 (Vandetanib; ZACTIMA) Plus the Proteasome Inhibitor, Bortezomib (Velcade® (Registered Trademark)), in Adults with Solid Tumors with a Focus on Hereditary or Sporadic, Locally Advanced or Metastatic Medullary Thy

* 09-C-0082:
Phase I/II Study of B Cell Malignancies using T Cells Expressing an Anti-CD19 Chimeric Receptor: Assessment of the Impact of Lymphocyte Depletion Prior to T Cell Transfer

* 09-C-0080:
A Phase 2, Open-label, Proof-of-Concept Study to Assess the Ability to Detect Tumours and Angiogenesis via the Expression of Alpha v Beta 3 Integrin Receptors by (18F)AH-111585 PET Imaging

* 09-C-0079:
The Natural History of Solid Organ Cancer Stem Cells (SOCSC)

* 09-C-0077:
An Open-Label Clinical Trial of MORAb-009 in Combination with Pemetrexed and Cisplatin in Subjects with Mesothelioma

* 09-C-0076:
Retreatment Protocol for BL22 Immunotherapy in Relapsed or Refractory Hairy Cell Leukemia

* 09-C-0072:
Randomized Pilot Study for the Treatment of Cutaneous Leiomyomas with Botulinum Toxin

* 09-C-0065:
Phase 1 Trial of Siplizumab and Dose-Adjusted EPOCH-Rituximab (DA-EPOCH-R) in T and NK-Cell Lymphomas

* 09-C-0057:
A Phase II Study of Bevacizumab in Combination with Ixabepilone in Subjects with Advanced Renal Cell Carcinoma

* 09-C-0054:
A Group Wide Biology and Banking Study for Phase II Study of R1507

* 09-C-0053:
Autologous and Related Allogeneic Hematopoietic Stem Cell Transplant Data Submission to the Center for International Blood and Marrow Transplant Research (CIBMTR) and the National Marrow Donor Program (NMDP)

* 09-C-0052:
Informed Consent in Pediatric Phase I Cancer Trials

* 09-C-0051:
Phase II Study of Metastatic Melanoma Using a Chemoradiation Lymphodepleting Conditioning Regimen Followed by Infusion of Anti-Mart-1 and Anti-gp100 TCR-Gene Engineered Lymphocytes and Peptide Vaccines

* 09-C-0048:
A Phase I Study of ABT-888 in Combination with Metronomic Cyclophosphamide in Adults with Refractory Solid Tumors and Lymphomas

* 09-C-0047:
Phase II Study of Metastatic Cancer that Expresses Carcinoembryonic Antigen (CEA) using Lymphodepleting Conditioning Followed by Infusion of Anti-CEA TCR-Gene Engineered Lymphocytes

* 09-C-0043:
A Single-Dose Study Evaluating the Oral Bioavailability and Pharmacokinetics of the Capsule Formulation of ABT-263 in Subjects with Cancer

* 09-C-0041:
Phase I/II Study of Metastatic Cancer that Expresses Her-2 Using Lymphodepleting Conditioning Followed by Infusion of Anti-Her-2 Gene Engineered Lymphocytes

* 09-C-0037:
A Phase II Clinical Trial of Ixabepilone (Ixempra, BMS-247550, NSC 710428), an Epothilone B Analog, in Cervical Cancer

* 09-C-0025:
Phase II Trial of LMB-2, Fludarabine and Cyclophosphamide for Adult T-Cell Leukemia

* 09-C-0024:
A Phase I Study of Quadrivalent Human Papilloma Virus (HPV) (Types 6, 11, 16, 18) Recombinant Vaccine in HIV-Infected and HIV-Negative Pre-Adolescents, Adolescents and Young Adults

* 09-C-0019:
A Phase I Study of Dasatinib in Combination with Bevacizumab in Advanced Solid Tumors

* 09-C-0018:
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Oral Talactoferrin in Addition to Best Supportive Care in Adults with Non-Small Cell Lung Cancer (NSCLC) Who Have Failed Two or More Prior Treatment Regimens

* 09-C-0005:
Randomized Trial of Cladribine (CdA) with Simultaneous or Delayed Rituximab to Eliminate Hairy Cell Leukemia Minimal Residual Disease

* 09-C-0003:
A Phase I and Pharmacokinetic Single Agent Study of Pazopanib in Adults with Advanced Malignancies and Varying Degrees of Liver Dysfunction

* 09-AR-0006:
A Multi-Center, Open Label, 6-Month Treatment Study to Establish the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of Canakinumab (anti-IL-1 Beta Antibody) in Patients with NOMID / CINCA Syndrome

* 09-AA-0136:
The Effect of NK1R Antagonism on Alcohol Craving and PTSD Symptoms in Alcohol Dependent Patients with PTSD

* 08-NR-0190:
Effects of Chronic Musculoskeletal Pain and Opioidergic versus Placebo Interventions on Neuroendocrine Function in Men

* 08-NR-0132:
Evaluation and Diagnosis of Potential Research Subjects with Pain and Fatigue Syndromes

* 08-N-0215:
Understanding the Anatomy and Physiology of the Sensory Experience and its Role in Generating Tics in Tourette Syndrome

* 08-N-0212:
Intermittent Theta-Burst Transcranial Magnetic Stimulation (TBS) for the Treatment of Parkinson Disease

* 08-N-0198:
Warfighter Head Injury Study - a Comprehensive, Multidisciplinary Research Evaluation

* 08-N-0192:
Functional Neuro-Imaging of Strategy use During Human Behavior

* 08-N-0189:
The Relationship Between Temporal Discrimination and Cortical Excitability in Humans

* 08-N-0181:
Role of Neurotransmission and Functional CNS Networks in Spasmodic Dysphonia and Other Focal Dystonias

* 08-N-0161:
Noninvasive Language Mapping in Patients with Localization-Related Epilepsy

* 08-N-0153:
The Role of Autoimmunity in Neurologic Complications of Celiac Disease

* 08-N-0134:
Pilot Study of Tolerability of Lithium Therapy in Patients with Spinocerebellar Ataxia Type I (SCA1)

* 08-N-0095:
Assessment of Cerebral Circulation and Perfusion in Adults after Neonatal Carotid Occlusion

* 08-N-0044:
A Prospective Natural History Study of Patients with Neurofibromatosis Type 2 (NF2)

* 08-N-0040:
The Association Between Focal Dystonia (FD) and Complex Regional Pain Syndrome (CRPS)

* 08-N-0027:
HHV6B in Epilepsy Imaging and CSF Studies

* 08-N-0023:
Motor Cortex Reward Signaling in Parkinson Disease

* 08-N-0012:
L-Dihydroxyphenylserine (L-DOPS) for Norepinephrine Deficiency: Interactions with Carbidopa and Entacapone

* 08-M-0211:
Safety of Transcranial Direct Current Brain Stimulation (TDCS) for Improvement of Psychotic Symptoms and Cognitive Functioning in Childhood Onset Schizophrenia (COS)

* 08-M-0196:
An Investigation of the Antidepressant Efficacy of a Selective, High Affinity Enkephalinergic Agonist in Anxious Major Depressive Disorder

* 08-M-0158:
PET Imaging of Peripheral Benzodiazepine Receptors Using [11C](R)-PK 11195 and [11C]PBR28

* 08-M-0154:
An Investigation of the Relationship Between Donepezil Enhanced REM Sleep, Sleep Architecture and Behavior in the Prepubertal Child with Autism

* 08-M-0150:
An Investigation to Determine Whether Levels of P11 Protein in Peripheral Blood Cells Correlate with Treatment Response to Citalopram in Patients with Major Depressive Disorder

* 08-M-0124:
Measurement of P-glycoprotein Function in Alzheimer Disease, Parkinson Disease, and Frontotemporal Dementia Using Positron Emission Tomography

* 08-M-0066:
PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [11C]PBR28 in Neurological Disorders

* 08-M-0062:
Brain and Whole Body Imaging of P-Glycoprotein Function using [11C]dLop

* 08-M-0052:
fMRI Investigation of Cortical Reorganization and Phantom Limb Pain Following Amputation

* 08-M-0049:
Imaging of Cannabinoid CB1 Receptors Using [18F]FMPEP-d2

* 08-M-0048:
PET Test/Retest Brain Imaging of Cannabinoid CB1 Receptors Using [11C]MePPEP

* 08-M-0002:
Randomized, Double-Blinded, Placebo Controlled Study of the Effects of Atomoxetine on Cognitive Function in Patients with Schizophrenia and Normal Controls Based on COMT Genotype

* 08-I-0221:
Analysis of HIV-1 Replication During Antiretroviral Therapy

* 08-I-0201:
Pioglitazone for Hepatic Steatosis in HIV/HCV Co-infection

* 08-I-0184:
Studies in the Pathogenesis of Idiopathic Anaphylaxis

* 08-I-0171:
A Phase I, Open Label, CT to Evaluate the Safety, Tolerability and Immunogenicity of a Multiclade Recombinant HIV-1 Adenoviral Vector Vaccine, VRC-HIVADV014-00-VP In Uninfected Adults Randomized to Needle or Biojector Methods of Intramuscular Injection

* 08-I-0065:
VRC 206: A Phase I Study to Evaluate the Safety and Immunogenicity of an Ebola DNA Plasmid Vaccine, VRC-EBODNA023-00-VP, and a Marburg DNA Plasmid Vaccine, VRC-MARDNA025-00-VP, in Healthy Adults

* 08-I-0053:
Pilot (Phase I-II) Study of Valproic Acid (Depakote) for the Treatment of the Autoimmune Lymphoproliferative Syndrome (ALPS)

* 08-I-0034:
Validation of (1)H-Magnetic Resonance Spectroscopy for Quantification of Hepatic Triglyceride Content

* 08-HG-0224:
Clinical and Genetic Studies of VACTERL Association

* 08-HG-0122:
Patient-Provider Communication and Interaction in a Virtual Clinical Setting

* 08-HG-0059:
Studies of Skin Microflora in Healthy Individuals and Atopic Dermatitis Patients

* 08-H-0222:
Neuropsychological Effects of Immunosuppressive Treatment in Subjects with Aplastic Anemia

* 08-H-0186:
Safety and the Anti- Tumor Effects of Escalating Doses of Adoptively Infused Ex Vivo Expanded Autologous Natural Killer (NK) Cells Against Metastatic Cancers or Hematological Malignancies Sensitized to NK-TRAIL Cytotoxicity with Bortezomib

* 08-H-0185:
Technical Development of Interventional Cardiovascular Magnetic Resonance Imaging in Normal Volunteers

* 08-H-0177:
Multicenter International Lymphangioleiomyomatosis Efficacy of Sirolimus Trial (The MILES Trial)

* 08-H-0156:
Screening of Subjects to Determine Eligibility to Safely Participate in Blood Disorders Studies

* 08-H-0108:
Effects of Worksite Wellness Interventions on Vascular Function, Insulin Sensitivity and High-Density Lipoprotein in Overweight or Obese Women

* 08-H-0084:
Evaluation of Systemic Toxicity Associated with Allogeneic Peripheral Blood Stem Cell Infusion

* 08-H-0081:
Identification of Biomarkers in Exhaled Breath Condensates from Asthmatic Patients

* 08-H-0067:
Ciliary Dysfunction as an Underlying Etiology Linking Primary Ciliary Dyskinesia with Heterotaxy and Complex Congenital Heart Disease

* 08-H-0047:
A Randomized, Placebo-Controlled, Double-Blind Pilot Study of Pioglitazone Hydrochloride in Allergic Asthma

* 08-H-0046:
Co-Infusion of Umbilical Cord Blood and Haploidentical CD34+ Cells Following Nonmyeloablative Conditioning as Treatment for Severe Aplastic Anemia and MDS Associated with Severe Neutropenia Refractory to Immunosuppressive Therapy

* 08-H-0028:
Pilot Study of Monocyte Biology in Insulin Sensitive, Resistant and Diabetic Subjects

* 08-H-0016:
Effect of Fasting on the Size of Lymphangioleiomyomas in Patients with Lymphangioleiomyomatosis

* 08-EI-0175:
Pilot Study of the Evaluation of Sirolimus in the Treatment of Diabetic Macular Edema

* 08-EI-0169:
Evaluation and Treatment Protocol for Potential Research Participants with Ocular Diseases

* 08-EI-0147:
Pilot Study of Intravitreal Injection of Ranibizumab for Macular Telangiectasia without Neovascularization (MACTEL 2)

* 08-EI-0146:
Pilot Study of Intravitreal Injection of Ranibizumab for Macular Telangiectasia with Neovascularization (MACTEL 1)

* 08-EI-0135:
Pilot Validation Study of Computer Administration of Vision Targeted Quality of Life Instruments

* 08-EI-0129:
Pilot Study of Sunitinib Malate for Advanced Ocular Disease of Von Hippel-Lindau Syndrome

* 08-EI-0103:
High Speed Indocyanine Green Angiography Findings in Induction/PRN Regimen of Intravitreal Ranibizumab Injection for Neovascular Age-Related Macular Degeneration

* 08-EI-0102:
Screening Study for the Evaluation and Diagnosis of Potential Research Participants

* 08-EI-0099:
Epigenetics, Molecular Genetics, and Biomarkers of Degenerative and Inflammatory Ocular Diseases

* 08-EI-0043:
Age-Related Eye Disease Study (AREDS) Follow-Up

* 08-EI-0031:
Visual Motor Coordination

* 08-DK-0182:
Viral Kinetics and Liver Gene Expression in Response to Ribavirin and Peginterferon Therapy of Chronic Hepatitis C

* 08-DK-0173:
A Trial of Segmental Stiffening Wires to Improve the Efficiency and Patient Tolerability of Colonoscopy

* 08-DK-0165:
Thyroid Hormones Homeostasis and Energy Metabolism Changes During Stimulation of Endogenously Secreted Bile Acids (BAs)

* 08-DK-0157:
A Trial of Oral Nifedipine for the Treatment of Iron Overload

* 08-DK-0138:
A New Method for Determining Gastric Acid Output Using a Wireless Capsule

* 08-DK-0106:
Hepatitis C Eradication and Progression of Atherosclerosis

* 08-DK-0098:
Natural History of Familial Carcinoid Tumor

* 08-DK-0004:
High Throughput Screening of Compound Libraries to Discover a Drug for the Treatment of Sickle Cell Disease

* 08-D-0018:
Clinical and Laboratory Evaluation of the Autonomic Nervous System in Primary Sjogren's Syndrome

* 08-CH-0213:
WAGR Syndrome and Other 11p Contiguous Gene Deletions: Clinical Characterization and Correlation with Genotype

* 08-CH-0203:
A Pilot Study to Assess the Feasibility of PTH 1-34 Therapy via Pump in the Management of Chronic Hypoparathyroidism

* 08-CH-0170:
Establishment of a Fibroid Tissue Bank

* 08-CH-0139:
Preventing Excessive Weight Gain in Adolescent Girls at High-Risk for Adult Obesity

* 08-CH-0085:
Eating Behavior in Adolescents

* 08-CH-0022:
Treatment of Menorrhagia in Women with Aplastic Anemia: Platelet Transfusion Alone to Platelet Transfusion with Continuous Oral Contraceptive Pills

* 08-CH-0001:
Calibration of Non-Invasive Non-Ionizing Imaging Techniques to Study Vasculature of Healthy Volunteers

* 08-CC-0220:
A Phase II Clinical Trial to Determine the Effectiveness of Problem Solving Education in Caregivers and Patients During Allogeneic HSCT

* 08-CC-0205:
Evaluation of Assessments of Motor Performance, Physical Impairments and Functional Abilities

* 08-CC-0133:
Response and Adaptation to Aerobic Exercise in Patients with Pulmonary Hypertension: Initial Studies for Establishing Guidelines

* 08-CC-0032:
Parental Permission and Adolescent Assent and Decision Making in Clinical Research

* 08-CC-0024:
Immunologic and Virologic Response in HIV Infected HLA-B*57 Progressors after Infusion of Lymphocytes from HIV Infected HLA-B*57 "Elite" Long-Term-Nonprogressors

* 08-C-0226:
A Pilot Study of 11C-Acetate Positron Emission Tomography (PET) and 3 Telsa Magnetic Resonance Imaging (MRI) in Men with Prostate Cancer Undergoing Prostatectomy

* 08-C-0223:
ADVL08N1: A Pharmacokinetic Participation Questionnaire Study

* 08-C-0214:
A Pilot Study to Evaluate Neuropsychological Outcome Measures and Their Relationship with Prognosis in Patients Receiving Radiation Therapy for Brain Metastases

* 08-C-0208:
Pilot Trial of Pioglitazone in Adults Undergoing Surgical Resection of Non-Small Cell Lung Cancer

* 08-C-0200:
A Pilot Study of 18F Fluorothymidine (FLT) PET/CT in Lymphoma

* 08-C-0180:
Phase I Trial of the Raf Kinase and Receptor Tyrosine Kinase Inhibitor Sorafenib (BAY 43-9006, Nexavar) in Children and Young Adults with Neurofibromatosis Type 1 and Inoperable Plexiform Neurofibromas

* 08-C-0179:
A Phase I Study of VEGF Trap (NSC #724770, IND #100137) in Children with Refractory Solid Tumors

* 08-C-0176:
First International Randomized Trial in Locally Advanced and Metastatic Adrenocortical Carcinoma Treatment (FIRM-ACT) Etoposide, Doxorubicin, Cisplatin and Mitotane vs Streptozotocin and Mitotane

* 08-C-0168:
A Phase II Trial of Sunitinib in the Treatment of Recurrent Malignant Gliomas

* 08-C-0166:
An Open Label Pilot Study to Evaluate the Effect on the Immune System of Talactoferrin in Adults with Non-Small Cell Lung Cancer (NSCLC)

* 08-C-0164:
A Phase II, Multicenter, Open-Label Trial Evaluating the Activity and Tolerability of Romidepsin (Depsipeptide, FK228) in Progressive or Relapsed Peripheral T-cell Lymphoma Following Prior Systemic Therapy

* 08-C-0162:
Transfer of Autologous T Cells Transduced with the Anti-MART-1 F5 T Cell Receptor in High Risk Melanoma

* 08-C-0155:
Phase II Study of Metastatic Cancer that Overexpresses p53 Using Lymphodepleting Conditioning Followed by Infusion of Anti-p53 TCR-Gene Engineered Lymphocytes and Dendritic Cell Vaccination

* 08-C-0151:
A Pilot Study of Sirolimus (Rapamycin, Rapammune[Registered Trademark]) in Subjects with Cowden Syndrome or Other Syndromes Characterized by Germline Mutations in PTEN

* 08-C-0148:
A Pilot Study of Imatinib Mesylate in Children and Adults with Sclerotic Skin Changes of Chronic Graft-Versus-Host Disease

* 08-C-0130:
A Phase II Trial of Peginterferon Alpha-2b (Pegintron) for Neurofibromatosis Type 1 Related Unresectable, Symptomatic or Life-Threatening Plexiform Neurofibromas

* 08-C-0128:
A Phase I Combination Study of AZD2281 and Cisplatin Plus Gemcitabine in Adults With Solid Tumors

* 08-C-0123:
A Phase 1, Multi-Center, Dose Escalation Study of CAT-8015 in Children, Adolescents, and Young Adults with Refractory CD22+ Acute Lymphoblastic Leukemia (pALL) or Non-Hodgkin's Lymphoma (NHL)

* 08-C-0121:
Phase II Study of Metastatic Cancer that Expresses NY-ESO-1 Using Lymphodepleting Conditioning Followed by Infusion of Anti-NY ESO-1 TCR-Gene Engineered Lymphocytes

* 08-C-0105:
Natural History Study of Monoclonal B Cell Lymphocytosis (MBL) and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

* 08-C-0104:
Phase II Study in Patients with Metastatic Melanoma Using a Non-Myeloablative Lymphocyte Depleting Regimen of Chemotherapy Followed by Infusion of gp100 Reactive Peripheral Blood Lymphocytes (PBL) and High or Low Dose Aldesleukin

* 08-C-0101:
A Phase 2 Trial of Tandutinib in Combination with Bevacizumab for Patients with Recurrent High-Grade Gliomas

* 08-C-0097:
Multi-Institutional Prospective Phase II Study of Montelukast for the Treatment of Bronchiolitis Obliterans Following Allogeneic or Autologous Stem Cell Transplantation in Children and Adults

* 08-C-0096:
A Phase II Study of the mTOR Inhibitor Sirolimus in Neurofibromatosis Type 1 Related Plexiform Neurofibromas

* 08-C-0092:
A Phase I Study with an Expansion Cohort of the PARP Inhibitor AZD2281 (KU-0059436) Combined with Carboplatin in Breast and Ovarian Cancer in BRCA1/2 Mutation Carriers and Familial Breast and Ovarian Cancer

* 08-C-0091:
Phase I Study of SNX-5422 Mesylate in Adults with Refractory Solid Tumor Malignancies and Lymphomas

* 08-C-0088:
Low Intensity Allogeneic Hematopietic Stem Cell Transplantation Therapy of Metastatic Renal Cell Carcinoma Using Early and Multiple Donor Lymphocyte Infusions Consisting of Sirolimus-Generated Donor Th2 Cells

* 08-C-0087:
Phase I Study of Vandetanib (ZD 6474) and Bevacizumab Combination Therapy Evaluating the VEGF and EGF Signal Transduction Pathways in Adults with Solid Tumors and Lymphomas

* 08-C-0086:
A Phase 2, Open-Label, Two Arm Trial to Evaluate the Efficacy of PF-00299804 in Patients with Advanced NSCLC After Failure of at Least One Prior Chemotherapy Regime and Failure of Prior Treatment with Erlotinib

* 08-C-0083:
Registration Ph III Study of Lucanix ™ (Trademark) in Adv NSC Lung Cancer: An Intl Mltctr RDBPC Study of Lucanix™ (Trademark) Maint Ther for Stages III/IV NSCLC Subjects Who Have Responded to or Have Stable Dx Following One Reg of Front-line, P

* 08-C-0080:
SARC Global Collaboration: A Phase II Trial of R1507, a Recombinant Human Monoclonal Antibody to the IGF-1 Receptor for the Treatment of Patients with Recurrent or Refractory Ewing's Sarcoma, Synovial Sarcoma, Rhabdomyosarcoma and Other Sarcomas

* 08-C-0079:
Natural History Study and Longitudinal Assessment of Children, Adolescents, and Adults with Neurofibromatosis Type 1

* 08-C-0078:
A Phase I/II trial of Pemetrexed (Alimta [Registered Trademark]) Combined with Sirolimus (Rapamycin, Rapamune [Registered Trademark]) in Subjects with Relapsed or Refractory NSCLC Whose Tumors Bear Activation of mTOR

* 08-C-0074:
A Phase II Study of Satraplatin and Prednisone in Metastatic Androgen Independent Prostate Cancer (AIPC)

* 08-C-0071:
Phase I Study of Bortezomib and Cetuximab without or with Cisplatin in Combination with Radiation Therapy for Advanced Head and Neck Cancer

* 08-C-0051:
A Pilot Trial of WT1 Peptide-Loaded Allogeneic Dendritic Cell Vaccine and Donor Lymphocyte Infusion for WT1-Expressing Hematologic Malignancies

* 08-C-0033:
A Multicenter Phase II Study of Belinostat (PXD-101) in Previously Chemotherapy Treated Thymoma and Thymic Carcinoma

* 08-C-0030:
Phase I Trial of Fenretinide (4-HPR, NSC 374551) Lym-X-Sorb (LXS) Oral Powder (4-HPR/LXS Oral Powder) (4-HPR) in Adults With Solid Tumors and Lymphomas

* 08-C-0026:
A Phase 1, Single Center, Dose-Escalation Study of SS1(dsFv)PE38 Administered Concurrently with Pemetrexed and Cisplatin in Subjects with Unresectable Malignant Epithelial Pleural Mesothelioma

* 08-C-0020:
A Phase 2 Study of ZD6474 (Vandetanib) in Patients with Von Hippel Lindau Disease and Renal Tumors

* 08-C-0015:
A Phase II Trial of Enzastaurin (LY317615) in Combination with Bevacizumab in Adults with Recurrent Malignant Gliomas

* 08-C-0007:
A Phase I Study of Ipilimumab (Anti-CTLA-4) in Children, Adolescents, and Young Adults with Treatment Refractory Cancer

* 08-AR-0218:
Phase II Trial of Rilonacept for Treatment of Familial Mediterranean Fever (FMF)

* 08-AA-0178:
Computer-Assisted Self-Administration of Ethanol (CASE) in Humans

* 08-AA-0137:
A Randomized, Double-blind, Placebo Controlled Trial (RCT) of Varenicline to Reduce Alcohol Consumption in Heavy Drinkers

* 08-AA-0125:
Effect of Naltrexone on Craving and Ethanol-Induced Brain Activity

* 08-AA-0058:
Modulation of Pharmacologically Induced Alcohol Craving in Recently Detoxified Alcoholics

* 07-N-0190:
Neurobiological Studies of Psychogenic Movement Disorders and Non-Epileptic Seizures

* 07-N-0187:
Brain Connectivity and Sensorimotor Integration During Single/Dual Motor Tasks

* 07-N-0165:
Suppression and Facilitation of the Motor Cortex by Stimulation of the Cerebellum in Patients with Dystonia and Healthy Controls

* 07-N-0156:
Biomechanics of Human Epiglottal Movement and Inversion

* 07-N-0154:
Influence of Lesion Location on Cortical Reorganization after Chronic Stroke

* 07-N-0147:
Effect of Direct Current Brain Polarization on Verbal Memory

* 07-N-0139:
Cross-Validating NIRS with fMRI

* 07-N-0137:
Expanding the Phenotype of the LRRK-2 Mutation in Individuals with History of Parkinson's Disease and their Relatives: a Prospective Study

* 07-N-0122:
Modulation of Motor Function by Stimulation of the Central and Peripheral Nervous System

* 07-N-0103:
Imaging Serotoninergic Neurotransmission in Epilepsy

* 07-N-0092:
PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [(11)C]PBR28 in Patients with Multiple Sclerosis (MS)

* 07-N-0072:
Neural Substrates of Lasting Motor Skill Learning by Spacing Effect

* 07-N-0063:
Detecting a Reward Signal in the Motor Cortex

* 07-N-0050:
MRI of Alzheimer's Disease Imaging Amyloid Plaques in Persons With and Without Memory Problems

* 07-M-0209:
PET Imaging of Peripheral Benzodiazepine Receptors in Patients with Neurocysticercosis Using [F-18]FBR

* 07-M-0208:
PET Imaging of Peripheral Benzodiazepine Receptors in Patients with Neurocysticercosis Using [C-11]PBR28

* 07-M-0129:
PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using (11C)PBR28 in HIV-Seropositive Patients with (MCMD)

* 07-M-0082:
PET Imaging of Brain mGluR5 Receptors Using [18F]SP203

* 07-M-0035:
PET Whole Body Imaging Using a Peripheral Benzodiazepine Receptor Ligand [C-11]PBR28

* 07-M-0021:
Development of Functional and Structural Magnetic Resonance Imaging Techniques for the Study of Mood and Anxiety Disorders

* 07-I-0229:
Influenza in the Normal and Immunocompromised Host

* 07-I-0218:
A Double-Blind, Randomized, Placebo-Controlled Cross-Over Study Assessing the Role of Pathogen-Specific IgE and Histamine Release in the Hyper-IgE Syndrome and the Effect of Ranitidine on Laboratory and Clinical Manifestations

* 07-I-0205:
An Observational Study of the Immunopathogenesis of and Response to Step-Up Inflammatory Bowel Disease Therapy for Hermansky-Pudlak Syndrome-Associated Colitis

* 07-I-0183:
The Collection of Research Samples and/or Data for Repository from Related or Unrelated Hematopoietic Stem Cell Transplantation Recipients for the National Marrow Donor Program

* 07-I-0171:
Treatment for Growth Failure in Patients with X-Linked Severe Combined Immunodeficiency (XSCID): A Phase 2 Study Assessing Safety and Clinical Response to Treatment with Insulin-like Growth Factor-1 (IGF-1)

* 07-I-0167:
VRC 012: A Phase I Clinical Trial of the Safety and Immunogenicity of an HIV-1 Adenoviral Vector Serotype 35 Vaccine: Dose Escalation as a Single Agent and Prime-Boost Schedules with an HIV-1 Adenoviral Vector Serotype 5 Vaccine in Uninfected Adults

* 07-I-0155:
A Ph I/IIa Rand Placebo Ctrl, S-Blind Multictr Dose-Esc Study of SC Intermittent Interleukin-7 CYT107 in Chronically HIV-Infected Pts with CD4 T Lymphocyte Counts 101-400 Cells-/mm(3) and Plasma HIV RNA Less Than 50 copies/mL After at Least 12 M of HAART

* 07-I-0142:
Research Respiratory Tract Procedures in Healthy Adult Volunteers and Adult Patients to Obtain Specimens for In Vitro Analyses of Infection Pathogenesis and Susceptibility

* 07-I-0075:
Allogeneic and Matched Unrelated Donor Stem Cell Transplantation for Congenital Immunodeficiencies: Busulfan-Based Conditioning with Campath- 1H or h-ATG, Radiation, and Sirolimus

* 07-I-0033:
Screening Protocol for Detection and Characterization of Infections and Infection Susceptibility

* 07-I-0017:
Autologous Transplantation of Genetically Modified Cells for the Treatment of X-Linked Chronic Granulomatous Disease

* 07-I-0001:
An Open Label Non-Randomized Trial to Assess Safety and Tolerability of Alb-Interferon Alfa 2b Every Two Weeks with Ribavirin among HIV/HCV Coinfected Individuals

* 07-HG-0204:
Deliberation with and without Attention: Can We Enhance Informed Choices about Invasive Prenatal Testing? A Proof of Principle Study

* 07-HG-0132:
Pilot Study of a Multi-Drug Regimen for Severe Pulmonary Fibrosis in Hermansky-Pudlak Syndrome

* 07-HG-0076:
A Phase One Treatment Trial of the Circadian Sleep Disturbance in Smith-Magenis Syndrome (SMS)

* 07-HG-0002:
ClinSeq: A Large-Scale Medical Sequencing Clinical Research Pilot Study

* 07-H-0225:
A Pilot Study of the Safety and Activity of Escalating Doses of ON 01910.Na in Patients with RAEB-1 AND RAEB-2 Myelodysplastic Syndrome (MDS) and AML with Trisomy 8

* 07-H-0196:
Niacin Therapy to Improve Endothelial Function in Sickle Cell Disease

* 07-H-0181:
Pulmonary Hypertension and the Hypoxic Response in SCD

* 07-H-0159:
Efficacy of WT1 and PRI Peptide Vaccination for Patients with Low Risk Myeloid Malignancies

* 07-H-0157:
Suburban/NHLBI Cardiovascular Disease Screening Protocol

* 07-H-0136:
Selective Depletion of Alloreacting T Cells Using a Photodepletion Technique to Prevent GVHD after HLA-Matched Peripheral Blood Stem Cell Transplantation for Subjects with Hematologic Malignancies

* 07-H-0113:
Collection of Blood, Bone Marrow, and Buccal Mucosa Samples from Healthy Volunteers

* 07-H-0104:
A Phase II Study of Lenalidomide Revlimid® (Registered Trademark) in Previously Treated Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

* 07-H-0091:
WTI Peptide Vaccination for Patients with High Risk Hematological Malignancies

* 07-H-0056:
Validation of Cardiac MR Perfusion with Cardiac Catheterization Physiological Assessment

* 07-H-0030:
Metabolic Regulation by Tumor Suppressor p53 in Li-Fraumeni Syndrome

* 07-H-0005:
Pilot Study of Topical Dexamethasone 0.01% Solution for Prevention of Oral Chronic Graft Versus Host Disease

* 07-EI-0145:
Ocular Impact of X Chromosome Karyotype and Sex Hormones in Turner Syndrome and Premature Ovarian Failure

* 07-E-0023:
Innate Immunity Signal Transduction in Human Leukocytes

* 07-DK-0219:
A Nutrigenomics Intervention for the Study of the Role of Dietary Sitosterol on Lipid, Glucose and Energy Metabolism

* 07-DK-0212:
Prospective Evaluation of Albuminuria in HIV Positive Patients

* 07-DK-0207:
Tenofovir Disoproxil Fumarate Alone Versus its Combination with Emtricitabine for Treatment of Chronic Hepatitis B

* 07-DK-0202:
Thyroid Hormones Homeostasis and Energy Metabolism Changes During Exposure to Cold Temperature in Humans

* 07-DK-0163:
The Effect of Diet on Vascular Disease: A Study of Pre-Menopausal African American and Caucasian Women

* 07-DK-0143:
Effects of S-Adenosyl Methionine (SAMe) on Viral and Cell Signaling Response to Combination Therapy for Chronic Hepatitis C

* 07-DK-0115:
Effect of Short-Term Beta-Cell Rest in Adolescents and Young Adults with Type 2 Diabetes Mellitus

* 07-DK-0077:
Study of the Phenotype of Overweight and Obese Adults

* 07-CH-0192:
Detection and Treatment of Endocrine Abnormalities in Childhood Cancer Survivors

* 07-CH-0126:
Pilot Study of the Metabolic Effects of Betahistine Hydrochloride (Obecure) in Overweight Women

* 07-CH-0008:
Prospective, Open-Label, Multicenter, International Study of Mifepristone for Symptomatic Treatment of Cushing's Syndrome Caused by Ectopic Adrenal Corticotrophin Hormone (ACTH) Secretion

* 07-CC-0011:
Hypnosis as a Pain and Symptom Management Strategy in Patients with Sickle Cell Disease

* 07-C-0230:
A Phase II Study of Hypofractionated Highly Conformal Radiation With Helical Tomotherapy for Extra-Cranial Oligometastases

* 07-C-0220:
A Phase I Study of Sunitinib (SU11248), an Oral Multi-Targeted Tyrosine Kinase Inhibitor, in Children With Refractory Solid Tumors

* 07-C-0210:
Phase I/II Study Using a Non-Myeloablative Lymphocyte Depleting Regimen of Chemotherapy Followed by Infusion of Allogeneic Tumor-Reactive Lymphocyte Cell Line DMF5 in Metastatic Melanoma

* 07-C-0206:
A Pilot Study of Tumor Vaccination in Patients with High Risk Pediatric Solid Tumors and Altered T Cell Homeostasis

* 07-C-0203:
A Phase I Study of ABT-888 in Combination with Topotecan Hydrochloride in Adults with Refractory Solid Tumors and Lymphomas

* 07-C-0195:
Pilot Trial of Targeted Immune-Depleting Chemo & Reduced-Intensity Allo Hematopoietic SCT Using 8/8 & 7/8 HLA-Matched Unrelated Donors and Utilizing 2 GVHD Prophy Regimens for the Tx of Leukemias, Lymphomas, & Pre-Malignant Blood Disorders

* 07-C-0189:
Phase I/II Trial of Vandetanib (ZD6474, ZACTIMA) in Children and Adolescents with Hereditary Medullary Thyroid Carcinoma

* 07-C-0176:
A Phase II Study Using Short-Term Cultured Anti-Tumor Autologous Lymphocytes Following a Lymphocyte Depleting Regimen in Metastatic Melanoma

* 07-C-0175:
Phase II Study of Metastatic Melanoma Using Lymphodepleting Conditioning Followed by Infusion of Anti-MART-1 F5 TCR-Gene Engineered Lymphocytes

* 07-C-0174:
Phase II Study of Metastatic Melanoma Using Lymphodepleting Conditioning Followed by Infusion of Anti-gp100:154-162 TCR-Gene Engineered Lymphocytes

* 07-C-0133:
Phase I Study of Topical Romidepsin (Depsipeptide) in Early Stage Cutaneous T-Cell Lymphoma

* 07-C-0130:
A Phase 1, Multicenter, Dose-Escalation Study of CAT-8015 in Patients with Relapsed or Refractory Hairy Cell Leukemia (HCL)

* 07-C-0123:
Pilot Trial to Identify and Characterize Breast Stem Cells in Women at Average Risk and Increased Risk for Breast Cancer

* 07-C-0121:
A Phase 2 Study of the c-Met RTK Inhibitor GSK1363089 (Formerly XL880) in Subjects with Papillary Renal-Cell Carcinoma (PRC)

* 07-C-0114:
A Phase I Study of Subcutaneous CYT 107 (Interleukin-7) in Refractory Metastatic Melanoma or Renal Cell Carcinoma

* 07-C-0111:
A Pilot Study of Markers of Tumor Burden and Radiation Toxicity in the Blood, Urine, and Stool of Patients Receiving Radiotherapy for Gastrointestinal Malignancies

* 07-C-0110:
Analysis of Stored Data Collected from Individuals Administered Neurobehavioral Assessments on IRB-Approved Protocols

* 07-C-0107:
A Randomized Phase II Trial Combining Vaccine Therapy with PROSTVAC/TRICOM and Flutamide vs. Flutamide Alone in Men with Androgen Insensitive, Non Metastatic (D0.5) Prostate Cancer

* 07-C-0106:
A Randomized Phase 2.5 Study of (153)Sm-EDTMP (Quadramet) with or without a PSA/TRICOM Vaccine in Men with Androgen-Insensitive Metastatic Prostate Cancer

* 07-C-0101:
A Phase 0 Trial of (111)Indium CHX-A" DTPA trastuzumab Imaging in Cancer

* 07-C-0100:
Collection of Blood from Patients with Prostate Cancer

* 07-C-0097:
A Phase I Study of Batracylin (NSC320846) in Subjects with Solid Tumors and Lymphomas

* 07-C-0087:
A Natural History Study of HIV Acquired in Infancy or Childhood

* 07-C-0086:
Pilot Study of Educational Interventions in Pediatric Hematopoietic Stem Cell Donors to Increase Knowledge of Donation and Transplantation Procedures

* 07-C-0085:
An Exploratory Study of the Use of Five Wishes as a Tool for Advanced Care Planning in Young Adults with Metastatic, Recurrent, or Progressive Cancer or HIV Disease

* 07-C-0081:
A Phase I/II Study of Flavopiridol in Relapsed or Refractory Mantle Cell Lymphoma (MCL) and Diffuse Large B-Cell Lymphoma (DLBCL)

* 07-C-0074:
A Phase II Study of ABT-751, an Orally Bioavailable Tubulin Binding Agent, in Children with Relapsed or Refractory Neuroblastoma

* 07-C-0064:
Adoptive Cell Therapy for B-Cell Malignancies After Allogeneic Hematopoietic Stem Cell Transplantation with Costimulated, Tumor-Derived Lymphocytes

* 07-C-0059:
A Phase II Study of AZD2171 in Metastatic Androgen Independent Prostate Cancer

* 07-C-0058:
A Phase II Study of Sorafenib and Bevacizumab in Epithelial Ovarian, Fallopian, and Peritoneal Cancer

* 07-C-0054:
A Phase I Trial and Pharmacokinetic Study of Trabectedin (YONDELIS [R], ET-743) in Children and Adolescents with Relapsed or Refractory Solid Tumors

* 07-C-0053:
A Phase I Trial of Enzastaurin (LY317615) in Combination with Carboplatin in Adults with Recurrent Gliomas

* 07-C-0047:
A Phase I Trial of Nelfinavir (Viracept) in Adults with Solid Tumors

* 07-C-0040:
A Phase I Trial of Monoclonal Antibody HGS-ETR2 (Lexatumumab) with or without Interferon Gamma in Patients with Refractory Pediatric Solid Tumors

* 07-C-0006:
A Phase 1/2a Study Evaluating the Safety, Pharmacokinetics and Efficacy of ABT-263 in Subjects with Relapsed or Refractory Lymphoid Malignancies

* 07-AT-0089:
An Exploratory Study to Evaluate the Ability of Epigallocatechin Gallate to Simultaneously Improve Metabolic and Cardiovascular Actions of Insulin in Healthy, Obese, Hypertensive, or Diabetic Subjects

* 07-AA-0026:
OPRM1 A118G SNP, Alcohol Response, and Striatal Dopamine

* 06-NR-0229:
Neurotropin Treatment of Fibromyalgia

* 06-N-0242:
The Effect of Surround Inhibition During Phasic Compared to Tonic Voluntary Finger Movement in Focal Hand Dystonia

* 06-N-0232:
Hypersensitivity in Tourette Syndrome: An Evaluation of Perceived Intensity Versus Threshold

* 06-N-0225:
Influencing Motor Performance in Patients with Stroke by Combined Theta Burst Stimulation and Carbidopa-Levodopa

* 06-N-0224:
Collection of Blood Samples for DNA Analysis in Motor Neuron Diseases

* 06-N-0174:
Cortical Function in Primary Lateral Sclerosis and Amyotrophic Lateral Sclerosis

* 06-N-0161:
Long-Term Motor Learning in Focal Hand Dystonia

* 06-N-0154:
An Exploratory Study on Detection of Cortical and White Matter Damage in Patients with Multiple Sclerosis Using Magnetic Resonance Imaging at 7 Tesla

* 06-N-0138:
Long-Term Improvement in Training Effects by Transcranial DC Stimulation

* 06-N-0128:
fMRI Studies of Task Specificity in Focal Hand Dystonia

* 06-N-0125:
Physiology of Weakness with Movement Disorders

* 06-N-0120:
Induction of Volitional Swallowing in Chronic Dysphagia Brain Injury: A Novel Mechanism-Based Intervention

* 06-N-0085:
Two-Compartment Model of Diffusion Tensor Magnetic Resonance Imaging (DT-MRI) for the Diagnosis of Glioma Tumor Recurrence versus Radiation Necrosis

* 06-N-0080:
Implicit Tactile Learning in Chronic Stroke Enhanced by Non-Invasive Brain Stimulation of the Somatosensory Cortex

* 06-N-0048:
Changes in Activation Patterns in the Ventro-Medial Prefrontal Cortex of Healthy Adolescents During the Imagination and Observation of Aggressive Behavior

* 06-N-0047:
Reference Values for Plasma Catechols

* 06-N-0031:
Evaluation of Density and Pattern of Distribution of GABA A Receptors in the Brain of Patients with Focal Hand Dystonia Studied with PET using [11C] Flumazenil

* 06-N-0012:
Moving a Paralyzed Hand through a Brain-Computer Interface Controlled by the Affected Hemisphere After Stroke or Traumatic Brain Injury

* 06-M-0246:
PET Scanning of Brain Dopaminergic Signal Transduction Involving Arachidonic Acid in Adults with Attention Deficit Hyperactivity Disorder (ADHD)

* 06-M-0234:
The Antidepressant Efficacy of the Anticholinergic Scopolamine

* 06-M-0215:
Antidepressant Effects on cAMP Specific Phosphodiesterase (PDE 4) in Depressed Patients

* 06-M-0214:
PET Measurement of Regional Rates of Cerebral Protein Synthesis in Subjects with Fragile X Syndrome

* 06-M-0155:
Identifying the Role of Oxytocin and Vasopressin in the Functioning of Neurocognitive Systems Involved in Mood Disorders

* 06-M-0102:
Clinical and Immunological Investigations of Subtypes of Autism

* 06-M-0065:
Screening Protocol for Studies of the Pediatric and Developmental Neuropsychiatry Branch

* 06-I-0217:
Genetic Disorders of Mucociliary Clearance

* 06-I-0207:
Investigation of Southern Tick-Associated Rash Illness (STARI)

* 06-I-0160:
Tumor Necrosis Factor Alpha Inhibitor (lnfliximab, Adalimumab) Treatment for Crohn's-like Inflammatory Bowel Disease in Chronic Granulomatous Disease: A Phase I/II Study Assessing Clinical and Immune Responses to Treatment and Genetic Influences

* 06-I-0153:
A Pilot Study of Hepatic Fibrosis in HIV/AIDS Patients with Chronically Elevated Transaminases on Antiretroviral Therapy

* 06-I-0086:
A Cohort Observational Study Evaluating Predictors, Incidence and Immunopathogenesis of Immune Reconstitution Syndrome (IRIS) in HIV-1 Infected Patients with CD4 Count Less Than or Equal to 100 Cells/micro L Who Are Initiating Antiretroviral Therapy

* 06-I-0077:
Voriconazole Plasma Concentration and Toxicity

* 06-I-0074:
Collection of Blood from Persons with Hemoglobin and Erythrocyte Polymorphisms for Laboratory Malaria Research

* 06-I-0049:
Studies of Disorders in Antibody Production and Related Primary Immunodeficiency States

* 06-I-0032:
Pilot Study of Omalizumab (Xolair) in Hyper IgE (Job's) Syndrome

* 06-I-0030:
Correlation of the Precursor Frequency of CD4 + Effector Memory T Cells with Induration Measured in the Tuberculin Skin Test (TST)

* 06-I-0015:
Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death

* 06-I-0005:
Evaluation of Risk Factors for Development of Epstein-Barr Virus Lymphoproliferative Disease

* 06-HG-0134:
Natural History and Biology of Dermal Neurofibromas in Neurofibromatosis Type 1

* 06-HG-0055:
Functional Imaging in Subjects with Glucocerebrosidase Mutations

* 06-H-0249:
Magnetic Resonance Angiography (MRA) in the Diagnosis of Atherosclerotic Disease Using High Field (3T) MRI Scanners: A Pilot Technical Development Study

* 06-H-0248:
Peripheral Blood Stem Cell Allotransplantation for Hematological Malignancies Using a Positive Stem Cell Selection Technique for T Cell Depletion, Followed by Delayed T Cell Add-Back

* 06-H-0222:
Role of Helicobacter Pylori and Its Toxins in Pulmonary and Oropharyngeal Disease

* 06-H-0208:
Cardiovascular Magnetic Resonance Imaging of Pediatric Healthy Volunteers

* 06-H-0202:
Cardiopulmonary Function Assessment and NO Based Therapies for Patients with Hemolysis-Associated Pulmonary Hypertension

* 06-H-0190:
Treatment of T-Large Granular Lymphocyte (T-LGL) Lymphoproliferative Disorders with Alemtuzumab (Campath)

* 06-H-0168:
An Open-Label, Baseline-Controlled Study of the Safety and Efficacy of SeeMore (EVP 1001-1 Injection) in Heart Patients

* 06-H-0156:
A Pilot Study of the Safety and Activity of Escalating Doses of AMD3100 to Mobilize CD34+ Cells in Healthy Volunteers

* 06-H-0072:
Atorvastatin as a Disease Modifying Agent in Stage II and III Pulmonary Sarcoidosis: A Randomized, Double-Blind, Placebo-Controlled Trial

* 06-H-0034:
A Randomized Study of Three Immunosuppressive Regimens in Treatment Naive Patients with Severe Aplastic Anemia: Horse-ATG/CsA Taper vs Rabbit-ATG/CsA vs Alemtuzumab

* 06-EI-0252:
A Novel Non-Invasive In Vivo Imaging System to Measure Retinal Metabolism

* 06-EI-0236:
National Ophthalmic Genotyping and Phenotyping Network, Stage 1 - Creation of DNA Repository for Inherited Ophthalmic Diseases

* 06-EI-0230:
Family Studies of Uveal Coloboma

* 06-EI-0111:
Treatment of Choroidal Subretinal Neovascularization with Agents Directed Against the Immune Response

* 06-EI-0068:
The Vitreous Proteome and Inflammatory Mediators in Ocular Inflammatory Disease

* 06-EI-0059:
Clinical and Molecular Studies in Families with Glaucoma and Related Diseases

* 06-EI-0058:
Clinical and Molecular Studies in Families with Myopia and Related Diseases

* 06-EI-0050:
Multicenter Uveitis Steroid Treatment (MUST) Trial Protocol

* 06-DK-0183:
Gene Expression and Release of Inflammatory Mediators in Overweight Subjects Before and After Weight Loss

* 06-DK-0142:
Peripheral Blood Collection of Adult Stem Cells

* 06-DK-0133:
Thyroid Hormone-Induced Lipolysis: An In Vivo Microdialysis Study

* 06-DK-0079:
The Role of the Orexin System in Body Weight Regulation: Patients with Narcolepsy

* 06-DK-0036:
Chronic Sleep Deprivation as a Risk Factor for Metabolic Syndrome and Obesity

* 06-DK-0025:
The Effects of Lithium Carbonate on Low Dose Radioiodine Ablation in Early Thyroid Cancer Treatment

* 06-DK-0020:
Kidney Disease Biomarkers

* 06-D-0206:
Open-Label, Dose-Escalation Study Evaluating the Safety of a Single Administration of AdhAQP1, an Adenoviral Vector Encoding Human Aquaporin-1 to One Parotid Salivary Gland in Individuals with Irradiation-Induced Parotid Salivary Hypofunction

* 06-D-0144:
Diagnosis, Evaluation and Treatment of Patients in Need of Third Molar Removal

* 06-CH-0223:
Biobehavioral Study of Recently Adopted Children

* 06-CH-0186:
Evaluation of Biochemical Markers and Clinical Investigation of Niemann-Pick Disease, Type C

* 06-CH-0119:
Insulin Resistance and Breast Cancer: Implications for Preventive Counseling in Familial and Sporadic Cases

* 06-CH-0038:
Body Heat Content and Dissipation in Obese and Normal Weight Adults

* 06-CH-0011:
Natural History Study of Patients with Excess Androgen

* 06-CH-0010:
Remodeling of Chromatin-Based Epigenetic Structures in Development and Aging

* 06-CC-0166:
Iron Replacement in Blood Donors

* 06-C-0250:
A Phase II Trial of Bevacizumab and Irinotecan for Patients with Recurrent High-Grade Gliomas Immediately Following Tumor Progression after Treatment w/Bevacizumab Alone: A Companion Trial to NCI Study 06-C-0064 (Bevacizumab Alone for Recurrent Gliomas)

* 06-C-0233:
A Phase I Study of the RAF Kinase and Receptor Tyrosine Kinase Inhibitor Sorafenib (BAY 43-9006, NSC# 724772 IND# 69896) in Children with Refractory Solid Tumors or Refractory Leukemias

* 06-C-0227:
Phase I Trial of Intravenous Fenretinide (4-HPR) for Patients with Hematologic Malignancies

* 06-C-0221:
A Phase I Trial of 5-Fluoro-2'-Deoxycytidine with Tetrahydrouridine in Advanced Malignancies

* 06-C-0219:
An Exploratory Study of Biologic and Pathophysiologic Effects of Radiation Therapy in Pediatric Patients with Central Nervous System Tumors

* 06-C-0211:
A Pilot Study to Investigate the Safety and Immunogenicity of a Peptide Vaccine for HIV Infected HLA-A2 Individuals Designed to Impede the Development of Antiretroviral Resistance

* 06-C-0200:
A Phase 1 Study of the Safety and Efficacy of GC1008: A Human Anti-Transforming Growth Factor-Beta (TGFBeta) Monoclonal Antibody in Patients with Advanced Renal Cell Carcinoma or Malignant Melanoma

* 06-C-0198:
A Pilot Pediatric/Adult Study of Gene Expression Profiling and Clinical Characterization of Phototoxicity

* 06-C-0177:
Microarray Analysis of the Effect of Cyclosporine Therapy on Gene Expression Patterns in Large Granular Lymphocytic Leukemia

* 06-C-0164:
A Phase II Study of BAY 43-9006 (Sorafenib) in Combination with Cetuximab (Erbitux™ (Trademark)) in EGFR Expressing Metastatic Colorectal Cancer (CRC)

* 06-C-0152:
Phase I Trial of CEDIRANIB (AZD2171), an Orally Bioavailable Antiangiogenic Agent, in Children and Adolescents with Refractory or Recurrent Solid Tumors or Acute Myelogenous Leukemia

* 06-C-0150:
A Phase II Clinical Trial of Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin for CD25 Positive Hairy Cell Leukemia

* 06-C-0115:
Studies on the Mechanism of Action of High-dose IL-2 in Metastatic Melanoma and Renal Cell Cancer

* 06-C-0112:
A Phase II Clinical Trial of the Histone Deacetylase Inhibitor Valproic Acid in Combination with Temodar and Radiation Therapy in Patients with High Grade Gliomas: Multi-Institutional Trial

* 06-C-0088:
A Random-Assignment Study of Hepatic Arterial Infusion of Melphalan with Venous Filtration via Peripheral Hepatic Perfusion (PHP) (Delcath System) Versus Best Alternative Care for Ocular and Cutaneous Melanoma Metastatic to the Liver

* 06-C-0083:
Phase I and Pharmacokinetic Study of BAY 43-9006 (Sorafenib) in Patients with Kaposi's Sarcoma

* 06-C-0064:
A Phase II Trial of Bevacizumab for Patients with Recurrent High-Grade Gliomas

* 06-C-0063:
A Phase I/II Trial of ZD6474 for Patients with Recurrent High-Grade and Progressive Low-Grade Gliomas

* 06-C-0060:
Dermoscopic Diagnosis, Histopathological Correlation, and Cellular Immortalization of Melanocytic Nevi and Primary Cutaneous Melanoma

* 06-C-0051:
AIDS-related Primary Central Nervous System Lymphoma: A Phase II Pilot Study of High-Dose Intravenous Methotrexate with Rituximab Leucovorin Rescue and Highly Active Antiretroviral Therapy

* 06-C-0043:
Phase II Trial of Chemotherapy in Sporadic and Neurofibromatosis Type 1 Associated High Grade Malignant Peripheral Nerve Sheath Tumors

* 06-C-0014:
Prospective Evaluation of Epigenetic Alterations in Patients with Thoracic Malignancies

* 05-N-0228:
The Role of Cortical Coherence in Focal Hand Dystonia

* 05-N-0223:
Clinical Neurophysiology: Training and Normative Values

* 05-N-0189:
Neuropathological Basis of Spasmodic Dysphonia and Related Voice Disorders

* 05-N-0179:
MRI Measurement of Brain Metabolism Across the Sleep-Wake Cycle

* 05-N-0142:
Effects of Unilateral and Bilateral Training on Motor Function in Chronic Stroke

* 05-N-0122:
Placebo Controlled Study of the Therapeutic Effect of the Transcranial Electrical Polarization in Patients with Focal Hand Dystonia

* 05-N-0063:
NINDS Biomarkers in Multiple Sclerosis Study (BioMS)

* 05-N-0039:
An Exploratory Study on Detection of Cortical Damage in Patients with Multiple Sclerosis Using Magnetic Resonance Imaging

* 05-M-0225:
An Investigation of the Efficacy in Childhood Obsessive-Compulsive Disorder of Riluzole: An Antiglutamatergic Agent

* 05-M-0198:
Effect of D-cycloserine on Treatment of Social Phobia

* 05-M-0169:
Dopamine Receptor Imaging in Mood Disorders

* 05-M-0157:
Top-Down Attentional Control of Visual Processing

* 05-M-0144:
MRS (Magnetic Resonance Spectroscopy) Measurement of Glutamate and GABA Metabolism in Brain

* 05-M-0110:
Intermediate Phenotype and Genetic Mechanisms for Psychosis and Cognitive Disturbance in 22q11.2-Hemideletion Syndrome

* 05-M-0105:
Investigating the Neuro-Cognitive Underpinnings of the Emotional Dysfunction Linked to Childhood Behavioral Disturbance

* 05-M-0059:
5HT1A and SERT Imaging During Pharmacologically Induced Hypogonadotropic Hypogonadism With and Without Estrogen and Progesterone Replacement

* 05-M-0035:
The Effects of Mood and Tryptophan Depletion on the Neural Correlates of Affective Shifting in Mood Disorders

* 05-I-0219:
Microarray Analysis of Erythema Migrans Lesions

* 05-I-0213:
Screening and Baseline Assessment of Patients with Abnormalities of Immune Function

* 05-I-0156:
A Study of Adjuvant Cytokine Therapy in Pulmonary Mycobacterium Avium Complex and other Pulmonary Nontuberculous Mycobacterial Infections

* 05-I-0084:
Clinical and Immunological Evaluation of Children with Allergic Disease

* 05-HG-0152:
Variation in Gene Expression in Neurofibromatosis Type 1

* 05-HG-0131:
Clinical Study of Muenke Syndrome (FGFR3-Related Craniosynostosis)

* 05-H-0244:
A Pilot Study of Recombinant Humanized Anti-CD20 Antibody (Rituximab) in Patients with Moderate Aplastic Anemia, Pure Red Cell Aplasia, or Diamond Blackfan Anemia

* 05-H-0242:
A Pilot Study of Alemtuzumab (Campath) in Patients with Relapsed or Refractory Severe Aplastic Anemia

* 05-H-0206:
A Pilot Study of Alemtuzumab (Campath[R]) in Patients with Myelodysplastic Syndrome (MDS)

* 05-H-0130:
Long-Term Evaluation and Follow Up Care of Patients Treated with Allogeneic Stem Cell Transplants

* 05-EI-0143:
Molecular Genetics of Retinal Degenerations

* 05-EI-0096:
Natural History and Genetic Studies of Usher Syndrome

* 05-DK-0119:
Peripheral Thyroid Hormone Conversion and Glucose and Energy Metabolism

* 05-DK-0085:
Clinical and Laboratory Investigation of Humans with Informative Iron or Erythroid Phenotypes

* 05-DK-0015:
Retinoids for Podocyte Disease

* 05-D-0103:
Genes Associated with Hereditary and Drug-Induced Gingival Overgrowth

* 05-D-0058:
Salivary Proteomics in Disease and Health

* 05-D-0052:
Stereo Photogrammetry Soft Tissue in Normal Individuals and Patients with Craniofacial Dysmorphologies

* 05-CH-0204:
Hypertonia in Patients with Cerebral Palsy

* 05-CH-0013:
Adrenal Function in Critical Illness

* 05-CC-0216:
Prospective Assessment of Functional Status, Psychosocial Adjustment, Health Related Quality of Life and the Symptom Experience in Patients Treated with Allogeneic Hematopoietic Stem Cell Transplantation

* 05-CC-0091:
Electromagnetic Tracking of Devices during Interventional Procedures: A Pilot Study

* 05-CC-0082:
The Influence of Concurrent Administration of Echinacea Purpurea, Ginkgo Biloba, or Panax Ginseng on the Steady State Pharmacokinetic Profile of Lopinavir/ritonavir in Healthy Volunteers

* 05-CC-0062:
Evaluation of Patients with Critical Illness: Intensive Care Training Protocol

* 05-C-0252:
Phase III Randomized Study of R-CHOP v. Dose-Adjusted EPOCH-R with Molecular Profiling in Untreated de Novo Diffuse Large B-Cell Lymphomas

* 05-C-0241:
A Pilot Study of Image Guided Prostate and Pelvic Nodal Irradiation with Intensity Modulated Radiation Therapy (IMRT) in Prostate Cancer

* 05-C-0229:
A Randomized Pilot Phase II Study of Docetaxel alone or in Combination with PANVAC-V (Vaccinia) and PANVAC-F (Fowlpox) in Adults with Metastatic Breast Cancer

* 05-C-0191:
A Phase I Study of Image Guided Dose Escalation with Intensity Modulated Radiation Therapy (IMRT) to Histologically Confirmed Regions of Prostate Cancer

* 05-C-0186:
A Pilot Trial of Oral Topotecan for the Treatment of Refractory Advanced Solid Neoplasms Expressing HIF-1 Alpha

* 05-C-0185:
Phase II Study of the Efficacy and Toxicity of Ontak (Denileukin Diftitox) in the Therapy of Adult T-Cell Leukemia

* 05-C-0170:
Randomized Phase II Study of Dose-Adjusted EPOCH-Rituximab-Bortezomib (EPOCH-R-B) Induction Followed by Bortezomib Maintenance versus Observation in Untreated Mantle Cell Lymphoma with Microarray Profiling and Proteomics

* 05-C-0137:
A Phase II Trial of Tamoxifen and Bortezomib in Patients with Recurrent High-Grade Gliomas

* 05-C-0049:
Phase II Study of Bay 43-9006 (Sorafenib) with Evaluation of RAS Signal Pathway in Patients with Relapsed Non-Small Cell Lung Cancer

* 05-C-0044:
Immunologic Studies of Tumors of the Pancreas

* 05-C-0010:
Phase I Study of Sequential Depsipeptide/Flavopiridol Infusion for Malignancies Involving Lungs, Esophagus, Pleura, Thymus or Mediastinum

* 05-AA-0121:
Assessment and Treatment of People with Alcohol Drinking Problems

* 05-AA-0120:
Acamprosate for Central Nervous System Hyperexcitability and Neuroadaptation in Alcohol Withdrawal

* 04-NR-0069:
Evaluation of Efficacy and Mechanisms of Topical Thalidomide for Chronic Graft-Versus-Host-Disease Related Stomatitis

* 04-N-0159:
Functional MRI (fMRI) and Diffusion Tensor Imaging (DTI) in Temporal Lobe Epilepsy

* 04-N-0113:
Examining Associative Relations in Structured Event Complexes Using Functional Neuroimaging

* 04-N-0071:
Phase I/II Study of HTLV-I-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) Using the Humanized MiK-beta-1 Monoclonal Antibody Directed Toward the IL-2/IL-15Rbeta Subunit (CD122) that Blocks IL-15 Action

* 04-N-0033:
MRI in Autosomal Dominant Partial Epilepsy with Auditory Features

* 04-M-0270:
Investigating the Role of Serotonin in Emotional Processing Through the Use of Tryptophan Depletion

* 04-M-0227:
Combining a Dopamine Agonist and Selective Serotonin Reuptake Inhibitor for Treatment of Depression: A Double-Blind, Randomized Study

* 04-M-0222:
Investigation of the Rapid (Next Day) Antidepressant Effects of an NMDA Antagonist

* 04-M-0221:
The Treatment of Menstrually-Related Mood Disorders with Extended Versus Interrupted Oral Contraceptives

* 04-M-0183:
Association between Adenosine Receptor Gene Polymorphisms and Physiological Responses to Caffeine in Subjects with Panic Disorder and Healthy Controls

* 04-M-0160:
Neural Correlates of Depressive Symptoms and Reward Related Mechanisms Following AMPT Depletion in Remitted Depressed Patients Off Treatment and Healthy Controls

* 04-M-0139:
The Effects of Dutasteride on Mood, HPA Axis, and Serum Allopregnanolone Levels in Women with Menstrual-Related Mood Disorders and Controls

* 04-M-0091:
An Investigation of a Pharmacologic Strategy to Bring About Rapid (Next Day) Antidepressant Effects

* 04-M-0002:
The Functional Neuroanatomy of Emotion Regulation in Major Depressive Disorder (MDD)

* 04-I-0286:
A Longitudinal Study of Familial Hypereosinophilia (FE): Natural History and Markers of Disease Progression

* 04-I-0231:
Procurement of Clinical Specimens for Immunologic or Genetic Studies in Inflammatory Bowel Diseases

* 04-I-0126:
Exhaled Breath Condensate as a Measurement of Airway Inflammation in Children with Asthma

* 04-I-0086:
Evaluation of Clinical, Virologic and Immunologic Factors that Contribute to the Pathogenesis of Chronic Hepatitis C and its Complications

* 04-I-0030:
Clinical Evaluation and Management of Persons with Severe Acute Respiratory Syndrome (SARS)

* 04-HG-0226:
Investigations of Megakaryocytes from Patients with Abnormal Platelet Vesicles

* 04-HG-0211:
Specimen Procurement from Individuals with Pulmonary Fibrosis

* 04-HG-0127:
Clinical and Basic Investigations of Methylmalonic Acidemia (MMA) and Related Disorders

* 04-HG-0123:
Bardet-Biedl Syndrome: Phenotype and Metabolic Characteristics

* 04-HG-0093:
Clinical and Genetic Studies on Holoprosencephaly

* 04-H-0202:
Human Diseases with Mutation of Non-Muscle Myosin Heavy Chain Genes

* 04-H-0161:
Studies of the Natural History of Sickle Cell Disease and Other Hemolytic Disorders

* 04-H-0012:
Collection of Blood, Bone Marrow, Urine, and/or Tissue Samples from Patients with Solid Tumors, Hematological Malignancies or Non-Malignant Hematologic Disorders or HLA Compatible Family Members

* 04-EI-0008:
Clinical and Molecular Studies in Families With Corneal Dystrophy or Other Inherited Corneal Diseases

* 04-DK-0021:
Urinary Vitamin C Loss in Subjects with and without Diabetes

* 04-D-0267:
Clinical Research Core Dental Screening Protocol

* 04-CH-0250:
Event Related Potentials in Infants and Adults

* 04-CH-0077:
Screening and Diagnosis of Patients With Connective Tissue Disorders

* 04-CH-0056:
The Neural Immune Mechanisms and Genetic Influences on Chronic Pelvic Pain in Women with Endometriosis

* 04-CH-0050:
Eating Behavior in Children

* 04-CC-0178:
The Treatment of Deep Vein Thrombosis of the Lower Extremities with "Low-Dose" Alteplase: a Pilot Study

* 04-CC-0119:
Biomarkers and Protein Mass Expression Profiles in Bronchoalveolar Lavage from Patients with Lung Infiltrates

* 04-C-0281:
Natural History Study of Clinical and Biological Factors Determining Outcomes in Chronic Graft-Versus-Host Disease

* 04-C-0275:
Targeted Oncolytic Virotherapy and Natural History Study of KSHV-Associated Multicentric Castleman's Disease with Laboratory and Clinical Correlates of Disease Activity

* 04-C-0274:
Follow-Up of Study Subjects Previously Enrolled in Immunotherapy Studies Utilizing Gene Transfer

* 04-C-0273:
A Phase II Study of Hepatic Arterial Infusion of Melphalan with Venous Filtration via Peripheral Hepatic Perfusion (PHP) for Unresectable Primary and Metastatic Cancers of the Liver

* 04-C-0257:
A Phase II Trial of Docetaxel, Thalidomide, Prednisone and Bevacizumab in Patients with Androgen-Independent Prostate Cancer

* 04-C-0232:
A Multi-Institutional Study of Proteomic Evaluation of Epithelial Ovarian Cancer, Primary Peritoneal Cancer, and Fallopian Tube Cancer Patients in First Clinical Remission: Development of a Protein Fingerprint Profile of Relapse

* 04-C-0200:
Urinary and Serum VEGF and MMP Levels in Patients Receiving Radiation Therapy for Glioblastoma Multiforme: Prospective Determination of a Predictive Value for Recurrence

* 04-C-0177:
A Pilot Study of Tc-94m Sestamibi PET MDR Imaging

* 04-C-0173:
Phase II Study of UCN-01 in Relapsed or Refractory Systemic Anaplastic Large Cell and Mature T-Cell Lymphomas

* 04-C-0165:
Medical Oncology Care in the NCI, Center for Cancer Research

* 04-C-0155:
Barrett's Esophagus Early Detection Study

* 04-C-0142:
A Phase II Clinical Trial of Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin for Treatment of CD25 Positive Cutaneous T-Cell Lymphomas

* 04-C-0121:
A Phase II Clinical Trial of Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin for Treatment of CD25 Positive Chronic Lymphocytic Leukemia

* 04-C-0116:
T-Cell Depleted, Reduced-Intensity Allogeneic Stem Cell Transplantation from Haploidentical Related Donors for Hematologic Malignancies (HAPLO Part A)

* 04-C-0102:
Hematologic Malignancy Biology Study

* 04-C-0089:
Phase I Open-Label Single-Dose Study of Humanized Mik-Beta-1 Monoclonal Antibody Directed Toward the IL-2R/IL-15R-Beta Subunit (CD122) in T Cell Large Granular Lymphocytic Leukemia

* 04-C-0081:
Pathogenesis and Course of Cutaneous T-Cell Lymphoma

* 04-C-0055:
Allogeneic HSCT without Preparative Chemotherapy or with Low-Intensity Preparative Chemotherapy using Sirolimus and Sirolimus-Generated Donor Th2 Cells for Therapy of Refractory Leukemia, Lymphoma, Myeloma, or Myelodysplastic Syndrome

* 04-C-0049:
A Phase I/II Study of an Antitumor Vaccination Using Alpha (1,3) Galactosyltransferase Expressing Allogeneic Tumor Cells in Patients with Refractory or Recurrent Non-Small Cell Lung Cancer

* 04-C-0001:
Phase II Study of Sequential Gemcitabine Followed by Docetaxel for Recurrent Ewing's Sarcoma, Osteosarcoma, or Unresectable or Locally Recurrent Chondrosarcoma

* 04-AR-0205:
Progression of Spinal Fusion in Ankylosing Spondylitis

* 04-AA-0060:
The Effect of Ethanol on Cerebral Blood Flow as Measured by Functional Magnetic Resonance Imaging and the Development of Conditioned Response to Ethanol Administration

* 04-AA-0058:
Positron Emission Tomography Imaging of Incorporation of Docosahexaenoic Acid (DHA) from Plasma into Human Brain

* 03-N-0260:
Functional Brain Mapping of Laryngeal Sensorimotor Control in Voice Disorders

* 03-N-0196:
Social Knowledge Representation in the Human Prefrontal Cortex

* 03-N-0171:
Combination Anti-platelet and Anti-coagulation Treatment After Lysis of Ischemic Stroke Trial (CATALIST)

* 03-N-0164:
Evaluation and Treatment of Neurosurgical Disorders

* 03-N-0142:
Development of 7 Tesla MRI Methodology for Anatomical Functional and Spectroscopic Imaging of the Brain

* 03-N-0119:
The Effects of an NMDA-Receptor Antagonist in Idiopathic Voice Disorders

* 03-N-0004:
Clinical Laboratory Evaluation of Primary Chronic Autonomic Failure

* 03-M-0292:
Psychobiological Mechanisms of Resilience to Trauma

* 03-M-0211:
Family Study of Affective and Anxiety Spectrum Disorders

* 03-M-0186:
The Psychobiology of Temperament: An fMRI Study

* 03-M-0185:
Generalized Anxiety Disorder and Social Anxiety Disorder: Their Impact on the Processing of Social Emotional Information and Instrumental Learning

* 03-M-0175:
The Effects of Acute Withdrawal of Estradiol on Mood Symptoms in Women with Perimenopausal Depression

* 03-M-0161:
The Efficacy of 17Beta-Estradiol in Postpartum-Related Depressive Illness

* 03-M-0149:
Functional MRI Study of Brain Mechanism Mediating Anhedonia in Major Depression

* 03-M-0143:
Randomized, Double-Blinded, Placebo Controlled Study of the Effects of Modafinil on Cognitive Function in Patients with Schizophrenia and Normal Controls Based on COMT Genotype

* 03-M-0138:
A Screening Protocol to Evaluate Women with Postpartum-Related Mood and Behavioral Disorders

* 03-M-0108:
Cholinergic Modulation of Cognition and Emotion in Mood Disorders: Functional Neuroimaging Studies

* 03-M-0102:
Effects of Hydrocortisone Infusion on Processing of Facially Expressed Emotion During Functional Magnetic Resonance Imaging

* 03-M-0093:
Predictability and Aversive Expectancies in Anxiety Disorders

* 03-M-0092:
An Investigation of the Antidepressant Efficacy of an Antiglutamatergic Agent in Bipolar Depression

* 03-M-0035:
Screening, Evaluation, Diagnosis, Treatment Optimization and Follow-up for Childhood Onset Psychotic Disorders

* 03-M-0014:
Neural Circuitry and Risk for Depression in Adolescents: A Study Using Functional Magnetic Resonance Imaging

* 03-M-0001:
Muscarinic Cholinergic Receptor Imaging in Depression

* 03-I-0285:
VRC 300: Screening of Healthy Volunteers for Clinical Trials of Investigational Vaccines to Prevent Infectious Diseases

* 03-I-0263:
Apheresis and Specimen Collection Procedures to Obtain Plasma, Peripheral Blood Mononuclear Cells (PBMCs) and Other Specimens for Research Studies

* 03-I-0090:
Immune Responses to Vaccinia Virus Vaccination

* 03-I-0041:
Determining the Pathogenesis of Systemic Pediatric-Onset Mastocytosis

* 03-HG-0313:
Genetic Analysis of Gray Platelet Syndrome

* 03-HG-0264:
Clinical Investigations into the Kidney and Liver Disease in Autosomal Recessive Polycystic Kidney Disease/Congenital Hepatic Fibrosis and other Ciliopathies

* 03-H-0280:
Disease Pathogenesis and Natural History of Lipid Disorders

* 03-H-0250:
Technical Development of Interventional Cardiovascular Magnetic Resonance Imaging

* 03-H-0249:
A Randomized Trial of Immunosupression in Aplastic Anemia Patients with Refractory Pancytopenia or Suboptimal Hematologic Response after h-ATG/CsA Treatment

* 03-H-0170:
Nonmyeloablative Allogeneic Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation For Severe Congenital Anemias Including Sickle Cell Anemia, Thalassemia, and Diamond Blackfan Anemia

* 03-H-0168:
Peripheral Blood Granulocyte Mobilization and Gene Expression Profiling in Adult Individuals of African Descent, With and Without Benign Ethnic Neutropenia

* 03-H-0105:
The Determination Of Genetic Basis Of Immunodeficiency

* 03-EI-0155:
Evaluation of Single Nucleotide Polymorphism (SNP) in Patients with and Subjects without Age-Related Macular Degeneration (AMD)

* 03-EI-0123:
Clinical and Molecular Studies in Families with Congenital or Hereditary Cataracts

* 03-EI-0122:
Evaluation of Immune Responses to Different Antigens in Non Infectious Ocular Inflammatory Diseases

* 03-EI-0033:
X-Linked Juvenile Retinoschisis - Clinical and Molecular Studies

* 03-E-0099:
Pathogenic Studies In Families With Twins Or Siblings Discordant For Systemic Rheumatic Disorders

* 03-DK-0257:
Effect of Leptin Therapy in the Treatment of Severe Insulin Resistance

* 03-DK-0256:
Inhibition of Intestinal Glucose Absorption by the Bioflavonoid Quercetin in the Obese and in Obese Type 2 Diabetics

* 03-DK-0226:
Pulse Dexamethasone Over 48 Weeks for Podocyte Disease

* 03-DK-0098:
Study of Thyrotropin Releasing Hormone in Patients with Thyroid or Pituitary Abnormalities

* 03-CH-0225:
Investigation of Simvastatin Therapy in Smith-Lemli-Opitz Syndrome

* 03-CH-0069:
Early Learning and Development Project

* 03-CH-0060:
Virtual Functional Anatomy (VFA)

* 03-CC-0128:
Development and Evaluation of Techniques for Computer Aided Detection and Diagnosis from Radiologic Images

* 03-CC-0015:
Collection of Blood from Volunteers and Patients for Studies of Endothelial Function and Systemic Inflammation

* 03-C-0278:
A Comparative Study of Pediatric CNS Tumor Activity as Assessed by [18]F-FDG PET Imaging and Proton Magnetic Resonance Spectroscopic Imaging ([1]H-MRSI)

* 03-C-0277:
Cell Harvest and Preparation for Surgery Branch Adoptive Cell Therapy Protocols

* 03-C-0241:
The Natural History of Childhood Malignancies Treated with Radiation Therapy

* 03-C-0066:
Hereditary Leiomyomatosis Renal Cell Cancer (HLRCC): Identification of the Disease Gene and Characterization of the Predisposition to Renal Cancer

* 03-C-0040:
A Multicenter Phase I-II Study of Tumor Vaccine Following Chemotherapy in Patients with Metastatic Breast Cancer Untreated with Chemo/Radiation in the Previous 18 Months: Vaccine-Induced Bias of T-Cell Repertoire Reconstitution After T-Cell Re-Infusion

* 03-C-0030:
Phase I Trial of Romidepsin Given on Days One, Three, and Five in Patients with Thyroid and Other Advanced Cancers

* 03-AR-0298:
A Pilot Study with the IL-1 Receptor Antagonist Anakinra or Kineret and other IL-1 Receptor Antagonist Drugs in Patients with Neonatal Onset Multisystem Inflammatory Disease (NOMID/CINCA Syndrome)

* 03-AR-0173:
Studies of the Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases (NOMID/CAPS, DIRA, CRMO, Still's Disease, Behcet's Disease, and other Undifferentiated Autoinflammatory Diseases)

* 03-AR-0133:
Clinically Important Changes in Rheumatoid Arthritis

* 03-AR-0131:
Genetic Determinants of Ankylosing Spondylitis Severity - Longitudinal Study

* 03-AR-0130:
Genetic Determinants of Ankylosing Spondylitis Severity - Cross Sectional Study

* 02-NR-0133:
Evaluation of Efficacy and Mechanisms of an Antiinflammatory Intervention for Chemotherapy Related Mucosal Injury

* 02-N-0132:
In Vivo Mapping Of Structural and Biochemical Abnormalities In Patients With Primary Focal Dystonia

* 02-N-0128:
Evaluation of Tourette's Syndrome with Multimetabolite H-Magnetic Resonance Spectroscopy at 3T

* 02-N-0109:
Real-time Analysis of Scalp Electroencephalography and Magnetoencephalography during Production of Human Voluntary Movement

* 02-N-0104:
Interhemispheric Interactions Associated with Performance of Voluntary Movements in Patients with Stroke Motor Disability

* 02-N-0014:
Research Study of Specimens Obtained During Epilepsy Surgery

* 02-N-0010:
EEG Study of Movement-Related Center-Surround Organization in Hand Dystonia

* 02-N-0001:
Testing A Model of the Representational Knowledge Stored in the Human Prefrontal Cortex

* 02-M-0321:
fMRI Investigation of Explicit Cue and Contextual Fear

* 02-M-0263:
Psychopharmacology of Fear-Potentiated Startle in Humans

* 02-M-0239:
Randomized, Double-Blinded, Placebo Controlled Study of the Effects of Tolcapone and Entacapone on Cognitive Function in Patients with Schizophrenia and Normal Controls Based on COMT Genotype

* 02-M-0120:
The Efficacy of Selective Estrogen Receptor Modulators in Perimenopause-Related Depression

* 02-M-0047:
Serotonin1A Receptor and Serotonin Transporter Imaging In Mood Disorders

* 02-M-0021:
Characterization and Pathophysiology of Severe Mood and Behavioral Dysregulation in Children and Youth

* 02-M-0007:
Adolescent Medial Temporal Lobe Function in Health and Illness

* 02-M-0003:
Fear Conditioning Using Computer-Generated Virtual Reality

* 02-I-0308:
Study of Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) for the Evaluation of the Autoimmune Lymphoproliferative Syndrome (ALPS) and ALPS-Associated Lymphoma

* 02-I-0286:
A Pilot Study of the Safety and Efficacy of Imatinib Mesylate in Reducing Eosinophilia in Patients with the Myeloproliferative Variant Hypereosinophilic Syndrome (HES) or Non-Myeloproliferative HES Refractory to Standard Therapy

* 02-I-0277:
Regulation of the Proliferation and Survival of Normal and Neoplastic Human Mast Cells

* 02-I-0232:
HIV Expression in Patients with Viral Loads Suppressed on HAART

* 02-I-0202:
Leukapheresis Procedures to Obtain Plasma and Lymphocytes for Research Studies on Antiretroviral Naive HIV-Infected Patients

* 02-I-0147:
Genetic Studies of Chronic Active Epstein-Barr Virus Infection

* 02-I-0127:
Screening Subjects for HIV Vaccine Research Studies

* 02-I-0110:
Natural History of Anthrax: A Study of Primary Infected, Recovered, and Exposed (SPoRE) Individuals and Evaluation of AVA Vaccinated Recipients

* 02-I-0096:
Rituximab (Anti-CD20) for the Treatment of Hepatitis C Associated Cryoglobulinemic Vasculitis

* 02-I-0086:
Leukapheresis Procedures to Study HIV-Specific Immunity

* 02-I-0055:
Evaluation, Treatment and Follow up of Patients with Lyme Disease

* 02-H-0250:
A Phase I/II Study of HLA-matched Mobilized Peripheral Blood Hematopoietic Stem Cell Transplantation for Advanced Mycosis Fungoides/Sezary Syndrome Using Nonmyeloablative Conditioning with Campath-1H

* 02-H-0160:
Peripheral Blood Stem Cell Collection from Adult Volunteers

* 02-H-0050:
Technical Development of Cardiovascular Magnetic Resonance Imaging

* 02-DK-0107:
Investigation of Neurodegeneration in Glycosphingolipid Storage Disorders

* 02-DK-0022:
Long-Term Efficacy of Leptin Replacement in Treatment of Lipodystrophy

* 02-CH-0311:
Investigations into Inborn Errors of Cholesterol Synthesis and Related Disorders

* 02-CH-0195:
Human MATER and Idiopathic Infertility

* 02-CH-0023:
Studies of Pediatric Patients with Metabolic or Other Genetic Disorders

* 02-CC-0266:
Acute Cardiac Allograft Cellular Rejection and Cardiac Allograft Vasculopathy: Identification of Diagnostic Biomarkers and Target Pathways for Preventive Therapy

* 02-CC-0247:
Values at the Bedside: A Survey of European Physicians Regarding Ethical Dilemmas in Clinical Practice

* 02-CC-0245:
The Natural History of Upper Trapezius Myofascial Trigger Points: Comparison of Local and Remote Tissue Milieu in Normal Muscle, Latent and Active Myofascial Trigger Points Over Time

* 02-CC-0045:
A Prospective (Cohort) Study to Identify Factors Affecting Morbidity Following the Diagnosis and Treatment of Patients with Breast Cancer: A Multi-Institutional Study Between NIH/RMD and NNMC/BCC

* 02-C-0284:
A Pilot Study of Ipilimumab (MDX-CTLA-4, MDX-010) in Lymphoma

* 02-C-0259:
Pilot Study of Allogeneic/Syngeneic Blood Stem Cell Transplantation in Patients with High-Risk and Recurrent Pediatric Sarcomas

* 02-C-0212:
Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian Cancer

* 02-C-0211:
Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Melanoma

* 02-C-0210:
Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Blood and Lymph Node Malignancy

* 02-C-0205:
Phase I Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide Infusion with or without Concurrent Celecoxib in Subjects with Pulmonary and Pleural Malignancies

* 02-C-0193:
A Phase II Study Of Pegylated Interferon Alfa-2b (Peg-Intron (TM)) In Children With Diffuse Pontine Gliomas

* 02-C-0186:
Eligibility Screening of Patients with CNS Tumors for NCI Clinical Research Protocols

* 02-C-0179:
Collection of Blood from Patients with Cancer

* 02-C-0178:
Multidisciplinary Etiologic Study of Familial Testicular Cancer

* 02-C-0159:
The Birt Hogg-Dube Syndrome: Identification of the Disease Gene and Characterization of the Predisposition of Renal Cancer

* 02-C-0144:
Establishment of Normal High Risk Breast Epithelial Cell Cultures, and A High Risk Cell Line and Tissue Repository from Breast Tissue from Women at High Risk of Breast Cancer

* 02-C-0140:
A Prospective National Study to Molecularly and Genetically Characterize Human Gliomas: The Glioma Molecular Diagnostic Initiative

* 02-C-0130:
A Phase II Clinical Trial of BMS-247550 (NSC710428), an Epothilone B Analog, in Renal Cell Carcinoma

* 02-C-0077:
Characterization of High Risk Breast Duct Epithelium by Cytology, Breast Duct Endoscopy, and cDNA Gene Expression Profile

* 02-C-0064:
Collection of Peripheral Blood and/ or Urine From Patients Undergoing Radiation Therapy

* 02-C-0052:
Etiologic Investigation of Cancer Susceptibility in Inherited Bone Marrow Failure Syndromes: A Natural History Study

* 02-C-0031:
Phase I Trial and Pharmacokinetic Study of BMS-247550 (NSC 710428, Ixabepilone), an Epothilone B Analog, in Pediatric Patients with Refractory Solid Tumors and Leukemias

* 02-AR-0131:
Collection Of Blood Components Using Apheresis From Patients With Rheumatic Diseases And Healthy Volunteers

* 01-N-0206:
Phenotype/Genotype Correlations in Movement Disorders

* 01-N-0148:
Spasticity: Physiologic Studies

* 01-N-0145:
Screening: Neurologic Disorders with Muscle Stiffness

* 01-N-0139:
Evaluation and Treatment of Patients with Epilepsy

* 01-N-0085:
Establishing the Pathophysiology of Primary Spinal Syringomyelia

* 01-N-0007:
Evaluation, Pathogenesis, and Treatment of Patients with or at Risk For Cerebrovascular Disease (A Natural History/Disease Pathogenesis Protocol)

* 01-M-0254:
The Evaluation of Patients with Mood and Anxiety Disorders and Healthy Volunteers

* 01-M-0232:
Positron Emission Tomography (PET) Scanning in Dopamine Disorders: Parkinson's Disease and Schizophrenia

* 01-M-0192:
Fluoxetine's Effects on Attention and Emotional Memory in Anxious and Depressed Youth and Adults

* 01-M-0185:
Effects of Arousal and Stress on Classical Conditioning

* 01-M-0152:
Adolescence, Puberty, Hormones, and Emotion Regulation: An fMRI Study

* 01-I-0238:
Diagnosis and Treatment of Leishmanial Infections

* 01-I-0226:
Evaluation of Immune Response to Vaccines in Primary Immune Disorders

* 01-I-0202:
Natural History, Genetics, Phenotype and Treatment of Mycobacterial Infections

* 01-I-0161:
Identification of Novel Viruses

* 01-I-0153:
The Immune Basis for the Gastrointestinal Complications of Common Variable Immunodeficiency

* 01-I-0004:
An Assessment of the Relationship Between Antiretroviral Drug Genotype/Phenotype (IC50) and Antiretroviral Activity in HIV-Infected, Drug-Experienced Patients with Suboptimal Suppression of Plasma Viral Load

* 01-HG-0189:
Treatment of SCID due to ADA Deficiency with Autologous Cord Blood or Bone Marrow CD34+ Cells Transduced with a Human ADA Gene

* 01-HG-0109:
Natural History Study of the Clinical and Molecular Manifestations of Smith-Magenis Syndrome (SMS)

* 01-HG-0106:
National Human Genome Research Institute Training Protocol

* 01-H-0198:
Clinical Course in Cystic Fibrosis: The Effects of Pseudomonas Aeruginosa and Potential Modifier Genes

* 01-H-0122:
Collection and Storage of Umbilical Cord Hematopoietic Stem Cells for Sickle Cell Disease Therapy

* 01-H-0088:
Determining the Prevalence and Prognosis of Secondary Pulmonary Hypertension in Adult Patients with Sickle Cell Anemia

* 01-DK-0062:
Genetic Analysis of Familial Keloids

* 01-DK-0053:
Permeability Factor in Focal Segmental Glomerulosclerosis

* 01-DC-0230:
Studies of Deficits in the Sense of Taste

* 01-DC-0229:
Genetic Analysis of Hereditary Disorders of Hearing and Balance

* 01-DC-0228:
Clinical and Molecular Analysis of Enlarged Vestibular Aqueducts

* 01-DC-0099:
Evaluation for NIDCD Head & Neck Surgery Branch Clinical Research Protocols

* 01-D-0184:
Evaluation and Treatment of Bone and Mineral Disorders

* 01-CH-0096:
Catecholamine Reserve and Exercise Tolerance in Subjects with Congenital Adrenal Hyperplasia and in Healthy Controls

* 01-CH-0086:
A Combination Therapy with Cystagon and N-Acetylcysteine for INCL Patients

* 01-CC-0231:
A Prospective Study of Transfusion-Transmitted Infections

* 01-CC-0045:
Studies of Phlebotomy Therapy in Hereditary Hemochromatosis

* 01-C-0158:
Protocol to Assess Vascularity in Kaposi's Sarcoma Lesions Utilizing Non-Invasive Imaging Techniques

* 01-C-0157:
Eligibility Screening and Tissue Procurement for the National Cancer Institute (NCI), Pediatric Oncology Branch (POB) Clinical Research Protocols

* 01-C-0144:
Surveillance of Invasive Fungal Infections in Bone Marrow/Stem Cell and Solid Organ Transplantation Recipients and Other Immunocompromised Patients: A Prospective Study

* 01-C-0129:
Eligibility Screening and Tissue Procurement for the National Cancer Institute (NCI) Center for Cancer Research (CCR) Clinical Protocols

* 01-C-0104:
A Phase I Study of Concomitant Therapy with Proteasome Inhibitor PS-341 and Radiation in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

* 01-C-0070:
Evaluation of the Natural History of Patients with Tumors of the Central Nervous System

* 01-C-0038:
Collection of Blood, Bone Marrow, Tumor, or Tissue Samples from Patients with HIV Infection, KSHV Infection, Viral-related Pre-malignant Lesions, and/or Cancer

* 01-C-0030:
Short-Course EPOCH-Rituximab for Untreated CD-20+ HIV-Associated Lymphomas

* 01-AR-0227:
Natural History of Rheumatic Disease in Minority Communities

* 00-NR-0200:
Neurotropin for Acute Dental Pain and for Chronic Neuropathic Pain

* 00-N-0158:
Trial of Intracerebral Infusion in Patients with Medically Intractable Epilepsy

* 00-N-0095:
Brain Activation During Developmental Speech Production and Speech Perception

* 00-N-0089:
Genetic Analysis of the Chiari I Malformation

* 00-N-0082:
Characterization of Brain Activation at 1.5 and 3.0 Tesla Using Perfusion Images and Blood Oxygen Level Dependent Images

* 00-N-0043:
Clinical and Molecular Manifestations of Inherited Neurological Disorders

* 00-M-0198:
The Phenomenology and Neurophysiology of Affective Dysregulation in Children and Adolescents with Bipolar Disorder

* 00-M-0103:
The Treatment of Menstrually-Related Mood Disorders with Continuous Gonadal Steroid Replacement

* 00-M-0085:
Structural and Functional Imaging of Neuropsychiatric Patients and Normal Volunteers with 3.0 Tesla MRI and Magnetoencephalography

* 00-I-0159:
Natural History, Management, and Genetics of the Hyperimmunoglobulin E Recurrent Infection (Job) Syndrome

* 00-I-0099:
Langherhans' Cell Function and Inflammatory Responses in Skin of Normal Volunteers and Patients with Helminth Infections Using the Suction Blister Technique

* 00-HG-0209:
Molecular and Clinical Studies of Primary Immunodeficiency Diseases

* 00-HG-0153:
Investigations into Chediak-Higashi Syndrome and Related Disorders

* 00-HG-0141:
Clinical, Biochemical, and Molecular Investigations into Alkaptonuria

* 00-HG-0058:
Genetic Analysis of Attention Deficit Hyperactivity Disorder (ADHD)

* 00-H-0051:
Cutaneous Tumorigenesis in Patients with Tuberous Sclerosis

* 00-H-0029:
A Pilot Study of Recombinant Humanized Anti-IL-2 Receptor Antibody (Daclizumab) in Patients with Moderate Aplastic Anemia, Pure Red Cell Aplasia, or Diamond Blackfan Anemia

* 00-EI-0135:
Study of Association of Serum Factors with Diabetic Retinopathy

* 00-DK-0221:
Evaluation of the Immune Response in Humans After Exposure to Hepatitis C Virus

* 00-DK-0125:
Immunogenetics of Hepatitis C Virus Infection

* 00-DK-0107:
Search for Novel Methods to Detect Acute Renal Failure

* 00-DC-0176:
Genetic Studies of Tune Deafness

* 00-DC-0073:
Identification of Hereditary Auditory Temporal Processing Deficits

* 00-CH-0219:
Turner Syndrome: Genotype and Phenotype

* 00-CH-0189:
FSH-Stimulated Inhibin B as a Marker for Early Ovarian Insufficiency

* 00-CH-0180:
Endocrine Studies in Health and Disease

* 00-CH-0160:
Clinical and Molecular Analysis of ACTH-Independent Steroid Hormone Production in Adrenocortical Tissue

* 00-CH-0136:
A Trial of Pamidronate in Children with Osteogenesis Imperfecta

* 00-CH-0127:
Evaluation of Patients with Endocrine-Related Conditions

* 00-CH-0093:
Diagnosis, Pathophysiology, and Molecular Biology of Pheochromocytoma and Paraganglioma

* 00-CH-0035:
The Development of Categorization

* 00-CC-0165:
Filgrastim-Mobilized Peripheral Blood Stem Cells for Primary Allogeneic Transplantation Using Unrelated Donors Participating in the National Marrow Donor Program (NMDP)

* 00-C-0181:
Evaluation for NCI Radiation Oncology Branch Clinical Research Protocols

* 00-C-0121:
A Phase I Investigation of IL-12/Pulse IL-2 in Adults with Advanced Solid Tumors

* 00-C-0078:
Collection of Blood, Bone Marrow, Tumor, or Tissue Samples from Patients with Cancer or Normal Volunteers

* 00-C-0074:
Evaluation of Late Effects and Natural History of Disease in Patients Treated with Radiotherapy

* 00-C-0030:
A Phase I/II Study of the Efficacy and Toxicity of Humanized Anti-Tac (Zenapax™ (Trademark)) in the Therapy of Tac-Expressing Adult T-Cell Leukemia

* 00-AR-0222:
Studies of the Pathogenesis and Natural History of Arthritis and Related Conditions

* 99-N-0178:
Feasibility of Neuromuscular Stimulation for Laryngeal Elevation During Swallowing

* 99-N-0009:
Sensory Function in Idiopathic Voice Disorders

* 99-M-0172:
Integrating EEG/MEG and fMRI: Activity Correlation between Frontal and Temporal Lobe Structures in Schizophrenic Patients, Their Siblings and Unrelated Normal Volunteers

* 99-I-0084:
To Develop a New Technique to Predict the Occurrence of Pneumocystis Pneumonia, Track its Epidemiology, Diagnose Acute Disease, and Predict and Monitor the Response to Various Therapeutic Agents

* 99-H-0076:
Fiberoptic Bronchoscopy in Patients with Asthma

* 99-H-0050:
Non-myeloablative Allogeneic Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematologic Malignancies in High Risk Patients and in Patients with Debilitating Hematologic Diseases

* 99-H-0037:
Apheresis of Family Members of Patients Undergoing Allogeneic Bone Marrow Transplantation. A Pre-Clinical Study of Selective Depletion of Donor Lymphocytes to Prevent Acute Graft-Versus-Host Disease

* 99-DK-0002:
Heart Disease Risk Factors in African Americans

* 99-D-0070:
Natural History of Salivary Gland Dysfunction and Sjogren's Syndrome

* 99-CH-0103:
Evaluation of Women with Endocrine and Reproductive-Related Conditions

* 99-CH-0055:
New Imaging Modalities in the Evaluation of Patients with Ectopic Cushing Syndrome

* 99-CC-0168:
Collection and Distribution of Blood Components from Healthy Donors for In Vitro Research Use

* 99-CC-0163:
Functional and Metabolic Imaging Using Magnetic Resonance at 3.0 Tesla

* 99-C-0158:
Treatment of Patients with Metastatic Melanoma Using Cloned Lymphocytes Following the Administration of a Non-Myeloablative but Lymphocyte Depleting Regimen

* 99-C-0128:
Evaluation for NCI Surgery Branch Clinical Research Protocols

* 99-C-0099:
Examination of Clinical and Laboratory Abnormalities in Patients with Defective DNA Repair: Xeroderma Pigmentosum, Cockayne Syndrome, or Trichothiodystrophy

* 99-AR-0004:
Molecular Basis of Primary Immunodeficiencies

* 98-N-0047:
Immuno-Virological Evaluation of Human T Cell Leukemia Virus Type-1 Associated Myelopathy (HAM/TSP)

* 98-I-0070:
Magnetic Resonance Imaging to Study Avascular Necrosis in HIV-Infected Subjects

* 98-I-0027:
The Characterization of CD34+ Derived Mast Cell Precursors Mobilized by Administration of Granulocyte Colony Stimulating Factor

* 98-HG-0249:
Genetic Analysis of Brain Disorders

* 98-H-0062:
Role of Exotoxins in the Pathogenesis of Pseudomonas Aeruginosa

* 98-D-0145:
Screening and Natural History of Patients with Polyostotic Fibrous Dysplasia and the McCune-Albright Syndrome

* 98-CH-0155:
Categorization Based on Motion-Carried Information in Infancy

* 98-CH-0081:
Clinical and Basic Investigations into Smith-Lemli-Opitz Syndrome

* 98-CC-0090:
Evaluation of Hematologic Patients - Training Protocol

* 98-CC-0019:
Normal Volunteer Scanning on MR

* 98-C-0037:
Treatment of Children with Cancer

* 98-AA-0056:
Functional Neuroanatomy of Positive and Negative Affect in Alcoholics and Non-Alcoholics

* 98-AA-0009:
Screening Evaluation for NIAAA Protocols

* 97-N-0070:
Training Protocol for Various Sleep Disorders in Patients with Neurological Disorders

* 97-I-0191:
Studies of Lymphocyte Kinetics Using Stable Isotopes

* 97-I-0096:
Evaluation, Treatment, and Monitoring of Patients With Known or Suspected Parasitic Infection

* 97-HG-0192:
Genetic Studies in the Amish and Mennonites

* 97-HG-0085:
Therapeutic Clinical Trial of Oral Pirfenidone for the Pulmonary Fibrosis of Hermansky-Pudlak Syndrome

* 97-H-0196:
A Phase II Study of HLA-Matched Peripheral Blood Stem Cell Transplantation for Metastatic Renal Cell Carcinoma as Adoptive Allogeneic Immunotherapy

* 97-H-0061:
Evaluation and Treatment of Pulmonary Patients not Participating in Research (Training Protocol)

* 97-H-0041:
Screening Protocol for Subjects Being Evaluated for Hematology Branch Protocols

* 97-H-0026:
Magnetic Resonance at 1.5 and 3 Tesla

* 97-H-0022:
Bronchoscopy in Patients with Pulmonary Diseases and Research Volunteers

* 97-DC-0180:
Genetic Analysis of Human Hereditary Hearing Impairment

* 97-DC-0057:
Non-Parametric and Parametric Linkage Studies of Stuttering

* 97-CH-0076:
A Clinical and Genetic Investigation of Pituitary Tumors and Related Hypothalmic Disorders

* 97-CH-0064:
Evaluation and Intervention for Ambulation, Basilar Invagination, and Secondary Effects of Osteogenesis Imperfecta

* 97-C-0178:
Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): DNA Microarray Gene Expression Analysis

* 97-C-0147:
Collection of Serum and Tissue Samples from Patients with Biopsy-Proved or Suspected Malignant Disease

* 97-C-0143:
Collection of Blood, Bone Marrow and Tissue Samples for the Investigation of the Human Immune Response, Lymphoma Biology and HTLV-1 Infection

* 97-C-0110:
Phase I/II Study of Tac-Expressing Malignancies Other than Adult T-Cell Leukemia (ATL) with Yttrium-90 Radiolabeled Humanized Anti-Tac and Calcium-DTPA

* 97-C-0028:
Clinical, Laboratory and Epidemiologic Pilot Studies of Individuals at High Risk for Viral-Associated Cancers

* 96-N-0089:
Characteristics of Idiopathic Familial Voice Disorders

* 96-N-0088:
Characteristics of Idiopathic Familial Speech Disorders

* 96-M-0124:
Genetics of Obsessive-Compulsive Disorder: A Collaborative Study

* 96-I-0129:
Evaluation and Long Term Follow-up of Patients with Allergic and Inflammatory Disorders

* 96-I-0085:
Genetic Studies of the X-Linked Lymphoproliferative Disease

* 96-I-0052:
A Comprehensive Clinical, Microbiological and Immunological Assessment of Patients with Suspected Chronic Lyme Infection and Selected Control Populations

* 96-H-0100:
Role of Genetic Factors in the Pathogenesis of Lung Disease

* 96-H-0049:
Use of Granulocyte Colony Stimulating Factor (G-CSF) Mobilized Leukapheresis Collections from Healthy Volunteers to Develop Improved Methods of Stem Cell and Lymphocyte Selection for Allogeneic Transplantation

* 96-CH-0101:
Population Differences in the Insulin Sensitivity, Resting Energy Expenditure, and Body Composition of Overweight Children and Children of Overweight Parents

* 96-C-0102:
Evaluation and Treatment of Subjects with Dermatologic Diseases

* 96-C-0097:
The Acquisition of Blood and Skin Samples from Patient Volunteers to Support Research Activities on Dermatologic and Other Diseases

* 96-C-0071:
Follow-up for Patients Previously Enrolled on the Center for Cancer Research Protocols

* 95-M-0150:
A Neurobiological Investigation of Patients with Schizophrenia Spectrum Disorders and Their Siblings

* 95-M-0097:
An Endocrine Model For Postpartum Mood Disorders

* 95-I-0066:
Genetic Analysis of Immune Disorders

* 95-I-0027:
Virologic and Immunologic Evaluation of Lymph Node, Tonsillar, and Intestinal Biopsies, and Bronchoalveolar Lavage Fluid

* 95-HG-0193:
Clinical and Basic Investigations into Hermansky-Pudlak Syndrome

* 95-HG-0165:
Outcomes of Education and Counseling for HNPCC / Lynch Syndrome Testing

* 95-H-0186:
Characterization of the Pathogenesis of Lymphangioleiomyomatosis (LAM)

* 95-H-0047:
Evaluation of Patients with Heart Disease Not Eligible for Research Protocols

* 95-CH-0110:
Endometrial Mediators of Gonadal Steroid Action

* 95-CH-0059:
Definition of the Genotype and Clinical Phenotype of Primary Pigmented Nodular Adrenocortical Disease (PPNAD), Carney Complex, Peutz-Jeghers Syndrome and Related Conditions

* 95-CC-0123:
Evaluation of Healthy Volunteer Marrow Donors Participating in the National Marrow Donor Program (NMDP)

* 94-I-0079:
Eosinophil Activation and Function in Parasitic Infections and Other Conditions with Increased Tissue or Peripheral Blood Eosinophilia in Humans

* 94-I-0073:
Recruitment of Peripheral Blood Hematopoietic Progenitors by Granulocyte Colony Stimulating Factor (G-CSF)

* 94-HG-0193:
Genetic and Clinical Studies of Congenital Anomaly Syndromes

* 94-HG-0132:
The Phenotype and Etiology of Proteus Syndrome

* 94-H-0010:
Evaluation, Treatment and Training Protocol for Patients with Bone Marrow Failure States, Isolated or Multilineage Cytopenias, Metastatic Solid Tumors, or Hematologic Malignancies

* 94-E-0165:
Studies in the Natural History and Pathogenesis of Childhood-Onset and Adult-Onset Idiopathic Inflammatory Myopathies

* 94-DK-0133:
Genetic Markers for Focal Segmental Glomerulosclerosis

* 94-DK-0127:
Pathogenesis of Glomerulosclerosis

* 94-D-0188:
Bone Regeneration Using Bone Marrow Stromal Cells

* 94-D-0018:
Salivary Evaluation in Normal Volunteers

* 94-C-0074:
Treatment and Natural History Study of Lymphomatoid Granulomatosis

* 94-AR-0105:
Genetics and Pathophysiology of Familial Mediterranean Fever and Related Disorders

* 94-AR-0066:
Studies of the Pathogenesis and Natural History of Systemic Lupus Erythematosus (SLE)

* 93-N-0202:
Diagnosis and Natural History Protocol for Patients with Different Neurological Conditions

* 93-M-0170:
Regional Cerebral Blood Flow Studies of Object Perception, Identification, Localization, and Memory

* 93-I-0119:
Detection and Characterization of Host Defense Defects

* 93-I-0106:
Cryptococcosis in Previously Normal Adults

* 93-I-0086:
Evaluation and Long Term Follow Up of Patients with Acute or Chronic Inflammatory Disorders

* 93-I-0063:
Study of the Immunopathogenesis, Natural History, and Genetics of Autoimmune Lymphoproliferative Syndrome (ALPS) Associated with an Expansion of CD4-8-/TCR alpha/beta+ T Cells

* 93-I-0057:
Apheresis Procedures to Obtain Plasma or Leukocytes for In Vitro Studies

* 93-DK-0127:
Family Studies in Metabolic Diseases and Mineral Metabolism

* 93-C-0133:
Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Patients with Aggressive Non-Hodgkin's Lymphoma

* 92-N-0226:
Establishing the Physiology of Syringomyelia

* 92-M-0174:
The Central Nervous System Effects of Pharmacologically Induced Hypogonadotropic Hypogonadism with and without Estrogen and Progesterone Replacement

* 92-I-0125:
A Study of Viral Burden in Peripheral Blood Versus Lymphoid and Bone Marrow Tissue in HIV-Infected Individuals

* 92-EI-0113:
Immunopathology and Molecular Pathology of Ocular Diseases in Humans

* 92-DK-0156:
Studies of Immunologically-Mediated Kidney Diseases

* 92-DC-0178:
Multimodal Studies of Language Production and Comprehension in Normal Volunteers and Patients with Neurologically-based Language Impairments

* 92-CH-0223:
Autoimmune Premature Ovarian Failure: A Controlled Trial of Alternate-Day Prednisone Therapy

* 92-CH-0034:
Studies of Growth Deficiency and Growth Hormone Treatment in Children with Osteogenesis Imperfecta Types III and IV

* 92-CH-0011:
Treatment of Hypoparathyroidism with Synthetic Human Parathyroid Hormone 1-34

* 92-C-0094:
Continuing Treatment for Children and Adults in the Center for Cancer Research

* 91-M-0230:
Mechanisms of Individual Variation of Dextroamphetamine Effects in Normal Human Subjects

* 91-M-0124:
Structural and Functional Imaging of Neuropsychiatric Patients and Normal Volunteers with 1.5 Tesla MRI

* 91-I-0140:
Studies of the Pathogenesis of HIV Infection in Human Peripheral Blood Cells and/or Reproductive Fluids in HIV-Infected and HIV-Uninfected Volunteers

* 91-DK-0214:
Evaluation of Patients with Liver Disease

* 91-DK-0085:
Studies of Hyperparathyroidism and Related Disorders

* 91-DK-0066:
Fasting Hypoglycemia: Diagnosis and Treatment

* 91-CH-0127:
Ovarian Follicle Function in Patients with Premature Ovarian Failure

* 91-CC-0117:
Epidemiology, Infectivity and Natural History of Hepatitis C Virus Infection in a Blood Donor Population

* 91-AR-0196:
Studies on the Natural History and Pathogenesis of Polymyositis, Dermatomyositis, and Related Diseases

* 90-M-0142:
Brain Procurement for the Neuropathology Section, CBDB

* 90-M-0088:
The Treatment of Menstrually-Related Mood Disorders with the Gonadotropin Releasing Hormone (GnRH) Agonist, Depot Leuprolide Acetate (Lupron)

* 90-M-0014:
Studies of Frontal Lobe Function During Cognitive Stimulation as Measured with Oxygen-15 Water Positron Emission Tomography in Normal Subjects and Patients with Neuropsychiatric Disorders

* 90-I-0120:
Comparison of Inflammatory Responses in Normal Volunteers and Patients with Abnormal Phagocyte Function Using the Suction Blister Technique

* 90-CH-0149:
Early Copper Histidine Therapy in Menkes Disease

* 90-CC-0168:
A Rigid Body Database on Human Movement

* 89-N-0045:
Evaluation of Progression in Multiple Sclerosis by Magnetic Resonance Imaging (MRI)

* 89-M-0160:
Inpatient Evaluation of Neuropsychiatric Patients

* 89-M-0006:
Brain Imaging of Childhood Onset Psychiatric Disorders, Endocrine Disorders and Healthy Controls

* 89-I-0158:
Studies of Immune Regulation in Patients with Common Variable Immunodeficiency and Related Humoral Immunodeficiency Syndromes

* 89-DK-0173:
Studies of States with Resistance to Vitamin D and Parathyroid Hormone

* 89-DK-0152:
Determination of Glomerular Filtration Rate, Effective Renal Plasma Flow and Glomerular Capillary Wall Permselectivity

* 89-C-0086:
Clinical Manifestations and Molecular Bases of Heritable Urologic Malignant Disorders

* 88-M-0131:
The Evaluation of Women with Perimenopause-Related Mood and Behavioral Disorders

* 88-I-0083:
Host Response to Infection and Treatment in the Filarial Diseases of Humans

* 88-CH-0032:
Specificity of Mother-Infant Interaction: The Influence of Maternal Age, Employment Status, and Parenthood Status

* 87-I-0163:
Apheresis Procedures to Obtain Plasma or Leukocytes for In Vitro Studies

* 87-DK-0029:
Diagnosis and Treatment of Patients with Cystic Fibrosis and Other Disorders of the Respiratory System and Pancreas

* 87-CC-0091:
Nuclear Magnetic Resonance Imaging/Spectroscopy at 1.5 and 3.0 Tesla

* 86-HG-0096:
Studies of Genetic Heterogeneity in Patients with Lysosomal Storage Disorders

* 86-EI-0062:
Trial of Topical Cysteamine in the Treatment of Corneal Cystine Crystal Accumulation in Cystinosis

* 85-N-0195:
A Training Protocol for the use of Botulinum Toxin in the Treatment of Neurological Disorders

* 85-I-0127:
Treatment of Cysticercosis including Neurocysticercosis with Praziquantel, Albendazole and other Novel Treatment Modalities

* 85-DK-0082:
Acromegaly Treatment and Natural History

* 84-M-0050:
Biochemical, Physiological, and Psychological Measures in Normal Controls and Relatives of Psychiatric Patients

* 84-D-0056:
Evaluation and Treatment of Salivary Gland Dysfunction

* 84-CH-0169:
Endocrine Studies of Healthy Children

* 83-C-0022:
Psychological Benefits of a Normalized Camping Experience for Children with Cancer

* 82-I-0183:
Study of the Immune Regulation of Idiopathic Inflammatory Bowel Diseases: Crohn's Disease, Ulcerative Colitis, and Other Inflammatory Conditions of the Gut

* 82-H-0032:
Comprehensive Evaluation of the Etiology and Pathogenesis of Chronic Lung Disease (Screening Protocol)

* 81-N-0010:
Regional Cerebral Utilization of Glucose in Patients with a Diagnosis of Frontal Lobe Dementia, Atypical Parkinsonian Disorder, and Other Basal Ganglia Disorders

* 81-M-0126:
The Evaluation of Women with Menstrually Regulated Mood and Behavioral Disorders

* 81-I-0164:
Apheresis Procedures to Obtain Plasma or Lymphocytes for In Vitro Studies

* 80-M-0083:
Bipolar Genetics: A Collaborative Study

* 79-H-0100:
Teaching Protocol for the Evaluation of Plasma Lipoproteins

* 78-I-0023:
Diagnosis and Management of Inflammatory and Infectious Diseases

* 78-HG-0093:
Natural History Study of the Use of Cysteamine in the Treatment of Cystinosis

* 78-C-0039:
Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Cancer

* 77-I-0094:
Study of Patients with Parasitic Infections of the Gastrointestinal Tract

* 77-DK-0096:
Studies on Thyroid Nodules and Thyroid Cancer

* 77-DK-0002:
Evaluation of Patients with Thyroid Function Disorders

* 76-N-0021:
Combined Clinical, Immunological and Virological Assessment of Patients with Multiple Sclerosis (MS)

* 76-HG-0238:
Diagnosis and Treatment of Patients with Inborn Errors of Metabolism

* 76-H-0051:
Lipoprotein Metabolism in Normal Volunteers and Hyperlipoproteinemic Patients

* 76-DK-0006:
Studies of Molecular Genetics of Insulin Secretion, Insulin Action, and Diabetes Mellitus

Active Followup, Protocols NOT Recruiting New Patients 

* 09-N-0117:
An Open Label Dose Escalation Safety Study of Convection-Enhanced Delivery of IL13-PE38QQR in Patients with Progressive Pediatric Diffuse Infiltrating Brainstem Glioma and Supratentorial High-Grade Glioma

* 09-I-0159:
A Randomized Double-Blind Control-Comparison Crossover Trial of Oral Glutamine to Suppress Frequently Recurrent Herpes Labialis

* 09-C-0038:
ATTAC: Anti-Tumor Immunotherapy Targeted Against Cytomegalovirus in Patients with Newly Diagnosed Glioblastoma Multiforme During Recovery from Therapeutic Temozolomide-induced Lymphophenia

* 08-N-0045:
Investigation of the Dopamine System in Frontotemporal Dementia

* 08-M-0006:
PET Imaging of Peripheral Benzodiazepine Receptors in Patients with Carotid Atherosclerosis

* 08-I-0093:
A Phase I Double-Blind, Placebo-Controlled, Dose-Escalating Study to Evaluate the Safety and Tolerability of Topical Nasal Poly-ICLC

* 08-I-0063:
A Phase III, Multicenter Placebo-Controlled, Randomized, Double-Blind Study to Evaluate Safety/Efficacy of PROCHYMALTM IV Infusion for Induction of Remission in Subjects Experiencing Tx of Refractory Moderate to Severe Crohn's Disease

* 08-H-0210:
Long Term Follow Up of Children and Adolescents Diagnosed with Hypertrophic Cardiomyopathy: Identification of Risk Factors that Predict Arrhythmia Events

* 08-DK-0187:
Natural History and Pathophysiology of Gastrointestinal Graft Versus Host Disease

* 08-DK-0149:
High Dose Ribavirin in Combination with Peginterferon for Patients with Chronic Hepatitis C Genotype 1 Infection Who Have Failed to Respond or Relapsed After Standard Therapy

* 08-DA-0437:
Psychology of Reward and Punishment: Functional and Molecular Brain Imaging and Monoaminergic Correlates

* 08-CC-0193:
Research Participant Perception of Care Project: Part 1: Focus Groups of Research Participants and Research Professionals to Identify Key Dimensions of the Research Participant Experience

* 08-C-0077:
A Phase I, Multi-Institutional, Open-Label, Dose-Escalation, Multiple Dose Study of the Safety, Tolerability, and Immune Response of CRS-207 in Adult Subjects with Selected Advanced Solid Tumors Who Have Failed or Who Are Not Candidates for Standard Tx

* 08-C-0075:
Phase III Evaluation of Recombinant MAGE-A3 Vaccine as Adjuvant Therapy Following Resection of MAGE-A3-Positive Non-Small Cell Lung Cancer

* 08-C-0056:
Phase II Study of Metastatic Melanoma Using Lymphodepleting Conditioning Followed by Infusion of Anti-MART-1 F5 TCR-Gene Engineered Lymphocytes and ALVAC Virus Immunization

* 08-C-0055:
Phase II Study of Metastatic Melanoma Using Lymphodepleting Conditioning Followed by Infusion of Anti-gp100:154-162 TCR-Gene Engineered Lymphocytes and ALVAC Virus Immunization

* 08-C-0039:
A Phase II Study of ZD6474 (Vandetanib) in Subjects with Advanced Clear Cell Renal Carcinoma

* 08-C-0035:
A Pharmacodynamic Study of the P-glycoprotein (Pgp) Antagonist, CBT-1® (Registered Trademark), Evaluating Pgp Inhibition in Tumors and Normal Tissues

* 08-AR-0029:
Phase Ib, MultiCenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety and Tolerability of Multiple IV Doses of MEDI-545, A Fully Human Anti-IFN-Alpha Monoclonal Antibody, in Patients w/SLE

* 08-AR-0008:
Insulin Resistance and Atherosclerosis in a Sample of Women with Systemic Lupus Erythematosus

* 07-N-0014:
The Use of Magnetic Resonance Imaging to Investigate Cortical Damage in Patients with Multiple Sclerosis and Correlation with Cognitive Dysfunction

* 07-M-0201:
An Investigation of the Efficacy of the Glutamate Transporter GLT 1 in the Treatment of Bipolar Depression

* 07-M-0152:
An Investigation of the Antidepressant Effects of the Selective NR2B Antagonist MK-0657 in Major Depression

* 07-M-0024:
Treatment of Childhood Regressive Autism with Minocycline: an Anti-Inflammatory Agent Active within the CNS

* 07-I-0094:
Accuracy of Hemoglobin A1C to Predict Glycemia in HIV

* 07-H-0177:
Treatment of Pulmonary Hypertension and Sickle Cell Disease with Sildenafil Therapy

* 07-EI-0213:
LI/National Eye Institute Repository

* 07-EI-0025:
The Age-Related Eye Disease Study 2 (AREDS2): A Multi-Center, Randomized Trial of Lutein, Zeaxanthin, and Omega-3 Long-Chain Polyunsaturated Fatty Acids (Docosahexaenoic Acid [DHA] and Eicosapentaenoic Acid [EPA]) in Age-Related Macular Degeneration

* 07-E-0012:
Rituximab in the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM)

* 07-D-0016:
Effects of Calcitriol vs. PTH Replacement Therapy on Bone in Patients with Hypoparathyroidism

* 07-CH-0193:
Use of GnRH Antagonist to Preserve Ovarian Function in Women Undergoing Chemotherapy

* 07-CH-0169:
Noninvasive Optical Imaging of the Effects of External Spectral Filters on Macular Autofluorescence in Pseudophakic Eyes

* 07-CC-0153:
Effects of Peripheral Blood Stem Cell Transplantation on the Microbial Flora of the Oral Cavity

* 07-CC-0125:
Pilot Study of the Incidence of HLA Class I and Class II Antibodies in Platelet Donors and their Effects on the Transfusion Recipient

* 07-CC-0090:
Molecular Changes and Biomarkers in Chronic Myeloproliferative Disorders

* 07-CC-0067:
A Feasibility Study to Test an Individualized Dyadic Problem-Solving Education Intervention to Improve Problem-Solving Skills of Patients and Family Caregivers During Allogeneic HSCT

* 07-CC-0015:
Exploring Decision Making of Hispanics and African Americans with HIV/AIDS Participating in Clinical Trials

* 07-C-0228:
Phase I and Pharmacokinetic Study of Vorinostat for Solid Tumors and Lymphomas in Patients with Varying Degrees of Hepatic Dysfunction: An NCI Organ Dysfunction Working Group Study

* 07-C-0200:
A Phase 1, Multicenter, Dose-Escalation Study of CAT-8015 in Patients with Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL)

* 07-C-0188:
A Double-Blind Randomized Phase 2.5 Trial of ONY-P1 Vaccine Versus Placebo in Men with D0 Prostate Cancer Following Limited Androgen Ablation

* 07-C-0108:
A Phase 1, Multicenter, Dose Escalation Study of CAT-8015 in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL), Prolymphocytic Leukemia (PLL), or Small Lymphocytic Lymphoma (SLL)

* 07-C-0061:
Phase II Study of Clinical Activity and Proteomic Pathway Profiling of the VEGFR2 Inhibitor, Vandetanib in Women With Relapsed or Refractory Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

* 07-C-0060:
Prospective Evaluation of Tumor Angiogenesis in Endocrine Neoplasms

* 07-C-0052:
A Phase 2 Study of O6-Benzylguanine (O(6)-BG) and Temozolomide in Patients with Glioblastoma Progressing at Least 3 Months After Completion of Primary Treatment with Radiation Therapy and Temozolomide

* 07-C-0003:
Phase II Study of Metastatic Cancer that Overexpresses p53 Using Lymphodepleting Conditioning Followed by Infusion of Anti-p53 TCR-Gene Engineered Lymphocytes

* 06-N-0243:
Brain Connectivity Between Visual Input and Motor Output

* 06-N-0212:
A Comparison of an Implanted Neuroprosthesis with Sensory Training for Improving Airway Protection in Chronic Dysphagia

* 06-N-0192:
Blepharospasm and the Experimental Modulation of Cortical Excitability in Primary and Secondary Motor Areas. A Pilot Study.

* 06-N-0113:
Phase II Clinical Trial to Examine the Efficacy and Safety of Dutasteride in Patients with Kennedy's Disease (Spinal and Bulbar Muscular Atrophy)

* 06-N-0096:
Testing Objective Measures of Motor Impairment in Early Parkinson's Disease

* 06-N-0022:
PET Imaging of GABA Receptors in Succinic Semialdehyde Dehydrogenase Deficiency

* 06-M-0253:
Evaluation of the Efficacy of the NK1 Antagonist GR205171 in Posttraumatic Stress Disorder

* 06-M-0002:
PET Whole Body Biodistribution and Test Retest Brain Imaging Studies Using a Phosphodiesterase 4 Inhibitor (R)-[11C]rolipram

* 06-I-0235:
A Phase II Vaccine Dose Finding Pilot Study for Development of an Anti-Influenza A (H5N1) Intravenous Hyper-Immune Globulin

* 06-I-0197:
A Randomized Placebo Controlled Trial of Atorvastatin in HIV Positive Patients Not on Antiretroviral Medications with the Specific Aims of Studying the Effects of Atorvastatin on HIV Viral Load and Immune Activation Markers

* 06-I-0180:
Evaluation of Alternative Oseltamivir (Tamiflu[R]) Dosing Strategies for Use during Influenza Prophylaxis

* 06-I-0149:
VRC 011: A Phase I Clinical Trial of Intramuscular, Subcutaneous and Intradermal Administration of an HIV-1 Multiclade DNA Vaccine, VRC-HIVDNA016-00-VP, and an HIV-1 Multiclade Adenoviral Vector Vaccine,VRC-HIVADV014-00-VP, in Uninfected Adult Volunteer

* 06-HG-0148:
Identity, Ancestry and Genetics: Patients' Perspectives

* 06-HG-0143:
Using Virtual Reality to Test Communication Strategies for Genomic Concepts

* 06-H-0228:
A Pilot Study of Fractionated Dose Subcutaneous Rituximab (RTX, Rituxan® (Registered Trademark)) in Patients with Refractory or Relapsed Chronic Lymphocytic Leukemia

* 06-H-0220:
Long-Term, Open-Label, Multicenter, Extension Study of Bosentan in Patients with Pulmonary Hypertension Associated with Sickle Cell Disease Completing a Double-Blind ASSET Study (AC-052-368 or AC 052-369)

* 06-H-0165:
Evaluation of Endothelial and Hemodynamic Function in HIV Associated Pulmonary Hypertension and a Phase I/II Safety and Efficacy Trial of Sildenafil in HIV Associated Pulmonary Hypertension

* 06-H-0124:
Randomized, Placebo-Controlled, Double-Blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Bosentan in Patients with Symptomatic Pulmonary Hypertension Associated with Sickle Cell Disease (ASSET 2)

* 06-H-0123:
Randomized, Placebo-Controlled, Double-Blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Bosentan in Patients with Symptomatic Pulmonary Arterial Hypertension Associated with Sickle Cell Disease (ASSET 1)

* 06-H-0122:
Mechanism and Vascular Effects of Endothelial Progenitor Cell Mobilization in Patients with Coronary Artery Disease Undergoing Cardiac Rehabilitation

* 06-H-0082:
Telomere Repair Gene Mutations in Inflammatory Bowel Disease

* 06-H-0062:
Safety of WT1 and PR1 Peptide Vaccination for Patients with Myeloid Malignancies

* 06-H-0054:
Evaluation of Synergy of Combining Hydroxyurea with Recombinant Human Erythropoietin Glycoform Alpha (rhu Erythropoietin-alpha) on Fetal Hemoglobin Synthesis in Patients with Sickle Cell Anemia

* 06-EI-0116:
A Phase II Study of OT-551 Antioxidant Eye Drop in Participants with Bilateral Geographic Atrophy Associated with Age-Related Macular Degeneration

* 06-DC-0218:
Neural Modeling and Brain Imaging of Tinnitus

* 06-D-0188:
Physiologic Regulation of FGF-23

* 06-D-0181:
A Randomized, Placebo Controlled, Proof of Concept, Study of Raptiva, a Humanized Anti-CD-11a Monoclonal Antibody, in Patients with Sjogren's Syndrome

* 06-CH-0201:
Effect of Transdermal Estradiol Replacement Therapy on Ovulation Rate in Women with Premature Ovarian Failure: A Randomized, Placebo-Controlled Trial

* 06-CH-0090:
Evaluation of Whether the Selective Progesterone Receptor Modulator CDB-2914 Can Shrink Leiomyomata

* 06-CH-0039:
Pilot Program for Targeted Prevention of Adolescent Weight Gain

* 06-C-0226:
A Phase I Pharmacokinetic and Pharmacodynamic Study of Temsirolimus (CCI-779) in Patients with Advanced Malignancies and Normal and Impaired Liver Function: An NCI Organ Dysfunction Working Group Study

* 06-C-0196:
A Study of the Safety, Tolerability, and Pharmacokinetics of MORAb-009, a Chimeric Monoclonal Antibody, in Subjects with Advanced Mesothelin-Expressing Tumors

* 06-C-0151:
Phase I Study of CDDO in Solid Tumors and Lymphomas

* 06-C-0118:
A Study Evaluating the Agreement of Devices for Measuring Temperature in Children

* 06-C-0089:
A Phase II Trial of 06-Benzylguanine and Temozolomide in Pediatric Patients with Recurrent or Progressive High-Grade Gliomas and Recurrent or Progressive Brainstem Tumors

* 06-C-0069:
Evaluation of the Impact of Adjuvants Accompanying Peptide Immunization in High Risk Melanoma

* 06-AT-0016:
A Randomized Study of the Effect of Tai Chi Chuan Compared to a Structured Exercise Program on Parameters of Physical Fitness and Stress in Adult Cancer Survivors

* 06-AA-0129:
NK1 Receptor Antagonism for Treatment of Anxiety and Craving in Anxious Alcohol Dependent Subjects During Early Abstinence

* 05-N-0245:
A Six Month Double-Blind, Placebo-Controlled Phase 2 Clinical Trial to Determine the Safety and Efficacy of Idebenone Administered to Patients with Friedreich's Ataxia

* 05-N-0092:
Clinical Trial Characterizing the Bioavailability of 1-Octanol in Adults with Ethanol-responsive Essential Tremor

* 05-N-0075:
Evaluation of the Mechanism of NO Formation and Pharmacokinetics of Long-Term Intravenous Nitrite Infusion in Healthy Volunteers

* 05-N-0036:
Recombinant Human Interferon Beta-1a in Acute Ischemic Stroke: A Dose Escalation and Safety Study

* 05-N-0018:
The Functional Anatomy of Personality Trait Knowledge: an fMRI Study

* 05-M-0102:
Neurobiological Mechanisms in Panic Disorder: Behavioral, Genetic, & Neural Correlates of Noradrenergic Function

* 05-M-0006:
The Effect of Gabapentin on Prefrontal GABA Concentration and Emotional Processing in Healthy Humans

* 05-I-0133:
Phase 1 Study of the Safety of Immunization of Naive Individuals with AMA1-C1/Alhydrogel [R], an Asexual Blood-Stage Vaccine for Plasmodium Falciparum Malaria, and the Effect of Immunization on Antigen-specific Memory and Plasma B Cells and T Cells

* 05-I-0127:
Assessing the Relationship Between Fatigue and Mitochondrial Toxicity in Patients with HIV/AIDS

* 05-I-0123:
A Randomized, Open-Label, International Study of Subcutaneous Recombinant Interleukin-2 (rIL-2, Aldesleukin) with and without Concomitant Antiretroviral Therapy in Participants w/HIV-1 Infection and CD4+ Cell Counts Greater Than or Equal to 300/mm(3)

* 05-I-0065:
A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Effect of Leflunomide on HIV-1 Associated Immune Proliferation In Vivo

* 05-HG-0236:
Pilot Study of the Use of Intravenous Immune Globulin in Hereditary Inclusion Body Myopathy

* 05-HG-0076:
Long-Term Clinical Trial of Nitisinone in Alkaptonuria

* 05-HG-0004:
Clinical Investigations into Hutchison-Gilford Progeria Syndrome

* 05-H-0163:
Relationship of Diastolic Function and Functional Capacity in Hypertrophic Cardiomyopathy: a Post-Hoc Analysis of Protocols 01-H-0066 and 96-H-0144

* 05-H-0114:
Evaluation of Systemic Nitrite Infusion and Its Effect on Exercise Physiology and Metabolism

* 05-H-0088:
Evaluation of the Mechanism of NO Formation and Pharmacokinetics of Systemic Nitrite Infusion

* 05-H-0019:
A Prospective, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of Nitric Oxide for Inhalation in the Acute Treatment of Sickle Cell Pain Crisis

* 05-H-0016:
Therapeutic Application of Intravascular Nitrite for Sickle Cell Disease

* 05-EI-0002:
A Phase I Clinical Trial to Study the Safety of a Sustained-Release Subconjunctival Cyclosporine Implant for Ocular Graft-vs-Host Disease (GVHD1)

* 05-DC-0238:
Effects of Sleep Deprivation and Recovery Sleep on Speech, Language and Other Higher Cognitive Functions: A Combined EEG-fMRI Study

* 05-D-0050:
Selective Venous Catheterization for the Localization of Phosphaturic Mesenchymal Tumors

* 05-CH-0168:
Short-Term Behavioral Effects of Cholesterol Therapy in Smith-Lemli-Opitz Syndrome

* 05-CH-0037:
The Effects of Hydrocortisone, Melatonin, and Placebo on Symptoms of Jet Lag

* 05-CC-0093:
The Effect of Animal-Assisted Therapy on Oncology Patients Being Treated for Pain

* 05-CC-0042:
Coupled Joint Proprioception and Multi-Joint Movement in the Lower Extremity: A Pilot Study

* 05-CC-0041:
Endothelial Cell Dysfunction in Pulmonary Arterial Hypertension: Biomarkers, Mechanisms of Disease and Novel Therapeutic Targets

* 05-CC-0012:
Effects of Inhaled Carbon Monoxide on Pulmonary Inflammatory Responses Following Endotoxin Instillation

* 05-CC-0008:
Revising Employee Benefits for the Sake of Health

* 05-C-0239:
A Phase I Trial and Pharmacokinetic Study of Talabostat (PT-100, VAL-BORO-PRO) in Combination with Temozolomide or Carboplatin in Pediatric Patients with Relapsed or Refractory Solid Tumors Including Brain Tumors

* 05-C-0232:
A Phase I Trial of Peginterferon Alfa-2b (PEG-Intron) for Plexiform Neurofibromas

* 05-C-0171:
Phase I Study of BL22, a Recombinant Immunotoxin for Chronic Lymphocytic Leukemia and CD22+ Lymphomas

* 05-C-0167:
Phase I Trial of a PSA based Vaccine and an anti-CTLA-4 Antibody in Adults with Metastatic Androgen Independent Prostrate Cancer

* 05-C-0150:
A Study of Central Nervous System Disease in Pediatric HIV in the HAART Era

* 05-C-0136:
A Phase I Trial of Enzastaurin (LY317615) in Patients with Recurrent Gliomas

* 05-C-0134:
A Biomarker and Phase II Study of GW572016 in Recurrent Malignant Glioma

* 05-C-0132:
A Phase I Trial of CC-5013 (Lenalidomide) in Pediatric Patients with Recurrent or Refractory Primary CNS Tumors

* 05-C-0031:
Randomized Trial of Patient-Specific Vaccination with Conjugated Follicular Lymphoma-Derived Idiotype with Local GM-CSF in First Complete Remission

* 05-C-0022:
A Phase I Trial of BAY 43-9006 (Sorafenib) and Bevacizumab in Refractory Solid Tumors with Biologic and Proteomic Analysis

* 05-C-0017:
A Phase I Feasibility Study of an Intraprostatic PSA-Based Vaccine in Men with Prostate Cancer and Local Failure Following Radiotherapy or Cryotherapy or Clinical Progression on Androgen Deprivation Therapy in the Absence of Local Definitive Therapy

* 05-AR-0014:
Continuation of a Pilot Open-Label Study of IL 1 Trap in Adult Subjects with Autoinflammatory Disease: A Therapeutic Approach to Study Pathogenesis

* 04-N-0210:
Towards the Establishment of Standards of Practice and the Initiation of Multi-Center, Multi-National Clinical Trials for Neonates and Children With Stroke

* 04-N-0192:
The Role of the Prefrontal Cortex in Economic Decision-Making in Reciprocal Trust Games Using Functional Hyperscanning Neuroimaging

* 04-N-0019:
Zenapax (daclizumab) Admin to Pts with Multiple Sclerosis (ZAP MS): Effect of Intravenously Admin Humanized Monoclonal Antibody against the Interleukin-2 Receptor Alpha Subunit (Daclizumab) on Inflammatory Activity in the Central Nervous System

* 04-N-0016:
Non-Invasive Seizure Localization in Patients with Medically Refractory Localization Related Epilepsy: Synchronized MEG-EEG Recordings

* 04-M-0136:
Neurocardiac Control in Major Depression

* 04-I-0289:
Secondary Transplantation Using Moderate Dose Busulfan as Conditioning for a Patient with Partial Reconstitution Post Initial Allogeneic Transplantation

* 04-I-0269:
An Open-Label Extension Study to Study 100185, to Evaluate Long-Term Safety, Efficacy and Optimal Dosing Frequency of 750 mg Intravenous Mepolizumab in Subjects with Hypereosinophilic Syndrome

* 04-I-0266:
Collection of Peripheral Blood and Bone Marrow From Healthy Donors for Use in In Vitro Research

* 04-I-0172:
A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of a Recombinant Multiclade HIV-1 Adenoviral Vector Vaccine, VRC-HIVADV014-00-VP, in Uninfected Adult Volunteers

* 04-I-0158:
A Multictr, Random, Dbl-Blnd, Placebo-Cntrld, Parallel Grp Ph III Study to Eval Corticosteroid-Reduction/Sparing Effects of Mepolizumab 750 mg IV in Subj w/HES, eval Efficacy/Safety of Mepolizumab in Controlling Clin Signs/Symptoms of HES over 9 Mos.

* 04-I-0018:
Phase II/III Study Evaluating the Effect of IL-2 on Preservation of the CD4 T-Lymphocytes After Interruption of Anti-Retroviral TX in HIV Infected Patients with CD4 T-Lymphocyte Count Greater Than 500 Cells/mm(3) Who Have Received Anti-Retroviral TX

* 04-H-0213:
Cytokine Gene Polymorphisms in Bone Marrow Failure

* 04-H-0198:
A Pilot Trial of an Accelerated Immunization Schedule with ALVAC-pp65 (vCP260) for Inducing CMV-Specific Immunity in Stem Cell Allotransplant Donors and Healthy Volunteers

* 04-H-0179:
Peripheral Blood Hematopoietic Progenitor Cell Mobilization Using Granulocyte Colony Stimulating Factor (G-CSF) Combined With AMD3100 in Healthy Volunteers

* 04-H-0143:
Modulation of Vascular Endothelial Growth Factor (VEGF) Using an Engineered Zinc-Finger Transcription Factor to Treat Lower Limb Intermittent Claudication

* 04-H-0112:
Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation Followed by T Cell Add-Back for Hematological Malignancies - Effect of Peritransplant Cyclosporine on Chimerism

* 04-H-0090:
A Pilot Study of the Safety and Efficacy of Imatinib in Reducing Monocytosis or Leukocytosis in Patients with Chronic Myelomonocytic Leukemia and Atypical Chronic Myelogenous Leukemia, Respectively

* 04-H-0078:
Peripheral Blood Hematopoietic Progenitor Cell Mobilization with AMD 3100 in Healthy Volunteers Previously Mobilized with G-CSF

* 04-DK-0193:
Identification and Mechanistic Investigations of Tolerant Kidney Transplant Patients

* 04-DK-0099:
Depletional Induction with Rabbit Anti-Thymocyte Globulin, Followed by Two Approaches Toward Monotherapy Immunosuppression in Kidney Transplant Recipients

* 04-DK-0061:
A Comparison of Free Fatty Acid Flux in African Americans and Caucasians

* 04-DK-0057:
Renal Transplantation in Recipients with Nephropathic Cystinosis

* 04-CH-0283:
Anthrax Vaccine Clinical Trials

* 04-CC-0184:
Influence of MDR-1 CYP3A4 and CYP3A5 Genotypes/Haplotypes on Sirolimus Pharmacokinetics and Pharmacodynamics in Patients with Renal Transplantation

* 04-CC-0130:
The Effect of a Systemic Oral Care Program on Reducing Exposure to Oropharyngeal Pathogens in Critically III Patients

* 04-CC-0070:
Exploring Patient-Provider Trust among Individuals with End-Stage Renal Disease

* 04-CC-0046:
Citrate Effects and Bone Density Studies in Long-Term Apheresis Donors

* 04-CC-0032:
Atorvastatin Therapy To Improve Endothelial Function in Sickle Cell Disease

* 04-C-0276:
A Pilot Study of a Three Month Intervention for Increasing Physical Activity in Sedentary Women at Risk for Breast Cancer

* 04-C-0263:
A Phase I Dose Escalation Study of Heat Activated Liposome Delivery of Doxorubicin and Radiofrequency Ablation of Primary and Metastatic Tumors of the Liver

* 04-C-0251:
A Study in Metastatic Melanoma Using a Lymphodepleting Conditioning Followed by Infusion of Anti-MART-1 TCR-Gene Engineered Lymphocytes and Subsequent Peptide Immunization

* 04-C-0246:
An Open Label Pilot Study to Evaluate the Safety and Tolerability of PANVAC-V (Vaccinia) and PANVAC-F (Fowlpox) in Combination with Sargramostim in Adults with Metastatic Carcinoma

* 04-C-0238:
A Phase II Study of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Von Hippel Lindau Disease and Renal Tumors

* 04-C-0218:
A Phase I Study of 17-Dimethylaminoethylamino-17-Demethoxygeldanamycin (17-DMAG) with Evaluation of HSP-90 Client Proteins in Patients with Solid Tumors and Lymphomas

* 04-C-0199:
Procurement of Normal Breast Tissue and Metastatic Breast Cancer Tissue for Molecular Profiling

* 04-C-0171:
A Prospective Histopathologic Study of Dynamic Contrast Enhanced MRI for Prostate Cancer Delineation and Characterization with the APT-MRI System

* 04-C-0167:
A Pilot Trial of a CEA-TRICOM Based Vaccine and Radiation to Liver Metastasis in Adults with CEA Positive Solid Tumors

* 04-C-0141:
A Pilot Phase I Dose Escalation Study of the EGFR Tyrosine Kinase Inhibitor (Iressa) Combined with Paclitaxel (Taxol) and External Beam Radiation Therapy in Patients with Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)

* 04-C-0131:
Allogeneic Breast Protocol 2: Phase I Trial of T cell Exchange with Th2/Tc2 Cells for Allogeneic Stem Cell Transplantation after Reduced Intensity Conditioning for Metastatic Breast Cancer

* 04-C-0095:
A Pilot Study of Intensified Lymphodepletion Followed by Autologous Hematopoietic Stem Cell Transplantation in Severe Systemic Lupus Erythematosus

* 04-C-0088:
Levels of Phosphorylated AKT in Patients with Node-Positive Breast Cancer: Correlation with Disease-Free and Overall Survival

* 04-C-0080:
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults with Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas

* 04-C-0044:
A Trial of Exemestane in Postmenopausal Women with DCIS or at High Risk for Invasive Breast Cancer

* 04-C-0031:
Phase I Trial of Medi-507 in CD2-Positive Lymphoproliferative Disease

* 04-C-0014:
Phase II Trial of BL22 Immunotoxin in Hairy Cell Leukemia

* 04-C-0011:
A Study of Combination Chemotherapy & Surgical Resection in the Tx of Adrenocortical Cancer: Mitotane & Continuous Infusion Doxorubicin, Vincristine & Etoposide w/the P-glycoprotein Antagonist, Tariquidar (XR9576), Before & After Surgical Resection

* 04-AA-0072:
Clinical Trial of the Cannabinoid CB1 Receptor Antagonist, SR141716 (Rimonabant), to Reduce Voluntary Ethanol Drinking in Healthy, Non-Treatment Seeking Individuals Who Consume Between 20 and 50 Drinks Per Week

* 03-N-0203:
SMN Levels in Peripheral Blood Samples of SMA Patients and the Effects of Pharmacological Compounds In Vitro

* 03-H-0282:
Characterization of Cardiac Function in Subjects with Hereditary Hemochromatosis Who Are New York Heart Association Functional Class I

* 03-H-0219:
A Genome-Wide Scan for Quantitative Trait Loci of Hematocrit - A Framingham Study

* 03-H-0201:
Cytokine Gene Polymorphisms in Allotransplant Donors

* 03-H-0193:
A Randomized Trial of a Novel Immunosuppressive Combination of ATG, CsA and Sirolimus (Rapamune) vs a Slow Taper Cyclosporine Regimen in Subjects with Severe Aplastic Anemia

* 03-H-0192:
Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation Followed by T Cell Add-back for Hematological Malignancies - Effect of Irradiated Donor Lymphocytes on Chimerism

* 03-H-0051:
Collection of Blood, Stool, Bone Marrow and/or Tissue Samples from Subjects with Hepatitis-Associated Aplastic Anemia

* 03-DK-0245:
Effect of AC2993 (Synthetic Exendin-4) - Administered Alone or in Combination with Daclizumab - On Islet Function in Patients with Type I Diabetes

* 03-DK-0136:
Low Dose Peginterferon and Ribavirin Therapy for Patients with Chronic Hepatitis C Infected with Genotype 2 or 3

* 03-DK-0132:
The Pathogenesis of Chronic Graft Failure after Kidney Transplantation

* 03-DK-0071:
Sirolimus Therapy in Idiopathic and Lupus Membranous Nephropathy

* 03-CC-0306:
A Phase I/II Randomized, Placebo-Controlled Trial to Assess the Safety and Efficacy of Intravenous Immunoglobulin G (Omr-IgG-am) Containing High Anti-West Nile Virus Antibody Titers in Patients with, or at High Risk for Progression to West Nile Virus(WNV

* 03-CC-0305:
Investigation of the Natural History of West Nile Virus Infection in Patients with Recently Acquired West Nile Fever or Neuroinvasive Disease

* 03-CC-0301:
Health Beliefs and Health Behavior Practices among Minorities with Rheumatic Diseases

* 03-CC-0127:
Evaluation of Potential Synergy of Combining Hydroxyurea with Nitric Oxide Donors on Fetal Hemoglobin Synthesis in Patients with Sickle Cell Anemia

* 03-CC-0091:
Global Initiative to Characterize Differences in Antiretroviral Pharmacokinetics in HIV-Infected Populations

* 03-CC-0052:
Influence of MDR1 Genotype on Indinavir and Saquinavir Pharmacokinetics in Healthy Volunteers

* 03-C-0304:
Pilot Trial of Alemtuzumab and Dose-Adjusted Epoch in Chemotherapy Naive Aggressive T and NK-Cell Lymphomas

* 03-C-0300:
A Phase II Randomized Trial Comparing TNFerade[TM] Biologic with Capecitabine and Radiation Therapy Followed by Surgical Resection Versus Capecitabine and Radiation Therapy Followed by Surgical Resection for the Treatment of Rectal Cancer

* 03-C-0284:
A Clinical Trial of the P-Glycoprotein Antagonist, Tariquidar (XR9576), in Combination With Docetaxel in Patients With Lung, Ovarian, Renal and Cervical Cancer: Analysis of the Interaction Between Tariquidar and Docetaxel

* 03-C-0228:
Characterization of Serum Proteomic Patterns in Neoplastic and Inflammatory Skin Disease

* 03-C-0216:
A Groupwide Biology and Banking Study for Ewing Sarcoma: Children's Oncology Group

* 03-C-0194:
Phase II Study of the Efficacy and Toxicity of Campath-1H in the Therapy of Adult T-Cell Leukemia

* 03-C-0190:
Trans-Rectal Placement of Prostatic Fiducial Markers Under MR-Guidance in Patients Receiving External Beam Radiotherapy for Prostate Cancer: A Pilot Study

* 03-C-0176:
A Phase I/II Pilot Study of Sequential Vaccinations with rFowlpox-PSA (L155)-TRICOM (PROSTVAC-F/TRICOM) Alone, or in Combination with rVaccinia-PSA (L155)-TRICOM (PROSTVAC-V/TRICOM), and the Role of GM-CSF, in Men with Prostate Cancer

* 03-C-0172:
Randomized Comparison of Peptide Immunization in Patients at High Risk for Recurrence of Melanoma

* 03-C-0152:
A Phase I Study of Subcutaneous "CYT 99 007" (Interleukin-7) in Patients with Refractory Non Hematologic Malignancy

* 03-C-0145:
Evaluation of the Natural History and Management of Pancreatic Lesions Associated with Von Hippel-Lindau

* 03-C-0124:
Follow-Up Study of Breast Cancer and Multiple Myeloma Subjects Previously Enrolled in Retroviral Gene Transfer Studies

* 03-C-0110:
Phase II Study of Intravenous Recombinant Humanized Anti-Vascular Endothelial Cell Growth Factor Antibody (Bevacizumab) in Classical (HIV-Negative) and in AIDS-Associated Kaposi's Sarcoma

* 03-C-0077:
A Pilot Study of EPOCH-F/R Induction Chemotherapy and Reduced-Intensity, HLA-Matched, Related Allogeneic Hematopoietic Stem Cell Transplantation, with Cyclosporine & Methotrexate GVHD Prophylaxis for Refractory or Relapsed Hematologic Malignancies

* 03-C-0038:
Phase I Study of HeFi-1 in Refractory CD30-Positive Malignancy

* 03-C-0002:
A Phase II Study of Peginterferon Alpha-2B (Peg-Intron(TM)) and Thalidomide in Adults with Recurrent High-Grade Gliomas

* 03-AA-0283:
Influence of Age and Sex on Alcohol Metabolism and Acute Responses

* 03-AA-0013:
Brain Activation in Response to Motivational and Affective Stimuli: Pharmacological Manipulations

* 02-N-0301:
ReoPro Retavase Reperfusion of Stroke Safety Study-Imaging Evaluation with Computed Tomography (ROSIE-CT)

* 02-N-0181:
Evaluation of Density and Pattern of Distribution of GABA A Receptors in Brain of Patients with Tourette's Syndrome Studied with PET using [11C] Flumazenil

* 02-N-0154:
ReoPro Retavase Reperfusion of Stroke Safety Study - Imaging Evaluation

* 02-M-0281:
The Characterization of Childhood Onset Obsessive Compulsive Disorder and the PANDAS Subgroup

* 02-M-0092:
Reward-Related Processes and Brain Function

* 02-M-0036:
A Behavioral and Functional Neuroimaging Study of Inhibitory Motor Control

* 02-I-0057:
Ex Vivo Retroviral Gene Transfer For Treatment of X-Linked Severe Combined Immunodeficiency (XSCID)

* 02-H-0265:
Identification of Genes Expressed in Atherosclerotic Plaques

* 02-H-0111:
Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation Followed by T Cell Add-Back for Hematological Malignancies - Role of Preparative Regimen and T Cell Dose in Graft Rejection and GVHD

* 02-DK-0065:
Combination of Pegylated Interferon and Ribavirin as Therapy for Patients with Chronic Hepatitis C with and without Renal Disease

* 02-DC-0008:
Assessment of Pre- and Post-Synaptic Dopamine Function in Developmental Stuttering Using 11C-Raclopride and Positron Emission Tomography

* 02-D-0169:
Complex Regional Pain Syndrome Proteomics Study

* 02-CH-0309:
The Diagnostic Performance of Screening Tests for the Diagnosis of Cushing's Syndrome

* 02-CH-0287:
Treatment of Leiomyomata with the Selective Progesterone Receptor Modulator CDB-2914

* 02-CH-0278:
Dyadic Interactions in Depressed and Non-Depressed Mothers with Their Infants

* 02-CH-0100:
Supplemental Calcium in Overweight Out-Patients

* 02-CC-0044:
Morbidity Following the Diagnosis and Treatment of Patients with Breast Cancer: A Multi-Institutional Study Between the National Institutes of Health (NIH) Rehabilitation Medicine Department (RMD) and the National Naval Medical Center (NNMC) Breast Care

* 02-C-0313:
Cancer Risk in Xeroderma Pigmentosum Heterozygotes

* 02-C-0268:
Prospective Study of Risk-Reducing Salpingo-Oophorectomy and Longitudinal CA-125 Screening Among Women at Increased Genetic Risk of Ovarian Cancer

* 02-C-0258:
Acquisition of Blood, Bone Marrow, Tumor, or Tissue Samples

* 02-C-0241:
A Phase I Trial of UCN-01 and Prednisone in Patients with Refractory Solid Tumors and Lymphomas

* 02-C-0215:
Amifostine as a Rectal Protector During External Beam Radiotherapy for Prostate Cancer: A Phase II Study

* 02-C-0207:
A Phase II Study of MR-Guided High Dose Rate Brachytherapy Boosts For Prostate Cancer

* 02-C-0149:
A Phase I Trial of High Dose Ketoconazole Plus Weekly Docetaxel in Metastatic Androgen Independent Prostate Cancer

* 02-C-0141:
Phase I Trial and Pharmacokinetic Study of ABT-751, An Orally Bioavailable Tubulin Binding Agent, on a 7 Day and 21 Day Dosing Schedule in Pediatric Patients With Refractory Solid Tumors

* 02-AT-0260:
A Phase I Study of the Effect of Mistletoe Extract, a Complementary, Medicine Botanical, on Pharmacokinetics, Pharmacodynamics and Safety of Gemcitabine in Patients with Advanced Solid Tumors

* 02-AT-0172:
A Randomized Study of Electroacupuncture Treatment for Delayed Chemotherapy-Induced Nausea and Vomiting in Patients with Pediatric Solid Tumors

* 02-AR-0272:
A Phase I, Open-Labeled, Dose-Ascending Clinical Trial of Immunotherapy of MRA, A Humanized Anti-IL 6 Receptor Monoclonal Antibody, In Patients with Systemic Lupus Erythematosus

* 02-AR-0156:
A Randomized, Double-Blind, Placebo-Controlled Trial of Infliximab In Patients With Dermatomyositis and Polymyositis

* 01-I-0225:
An Omnibus Proleukin (IL-2) Trial in HIV-Infected Patients Including Interrupted Versus Continuous Antiretrovirals (OPTICA): A Substudy of Interrupted Versus Continuous Antiretrovirals Involving Randomization From the Umbrella Study (ICARUS)

* 01-I-0171:
Substudies of ESPRIT: ESPRIT Influenza Vaccine Substudy (FLUVAC) and ESPRIT Tetanus-Pneumococcal Vaccine Substudy (TEPVAC)

* 01-H-0223:
Inhaled Nitric Oxide and Transfusion Therapy for Patients with Sickle Cell Anemia and Secondary Pulmonary Hypertension

* 01-H-0162:
Ex Vivo Selective Depletion of Alloreactive Donor T-Lymphocytes Utilizing RFT5-SMPT-dgA, a Specific Anti-Interleukin-2 Receptor Immunotoxin: Reducing GVHD Risk Associated with HLA-Matched, Nonmyeloablative, Peripheral Blood Stem Cell Transplantation for

* 01-H-0031:
National Heart, Lung, and Blood Institute Data Repository

* 01-DK-0249:
Ingested Interferon-Alpha: Prolongation or Permanence of the "Honeymoon" Phase in Newly Diagnosed Diabetes Mellitus

* 01-DK-0247:
Treatment of Chronic Delta Hepatitis with Pegylated Interferon

* 01-DK-0246:
Combination of Lamivudine and Adefovir Dipivoxil for Treatment of Chronic Hepatitis B

* 01-DK-0036:
Solitary Islet Transplantation for Type 1 Diabetes Mellitus Using Steroid Sparing Immunosuppression

* 01-C-0236:
Follow-Up of a Phase-I Gene Therapy Trial of Patients with Leukocyte Adherence Deficiency

* 01-C-0235:
Combination Antibody Therapy with Apolizumab (1D10) and Rituximab (CD20) in Relapsed Lymphoma and CLL

* 01-C-0222:
A Phase II Randomized, Cross-Over, Double-Blinded, Placebo-Controlled Trial of the Farnesyltransferase Inhibitor R115777 in Pediatric Patients with Neurofibromatosis Type I and Progressive Plexiform Neurofibromas

* 01-C-0173:
A Pilot Study to Evaluate Angiogenesis after Treatment with Bevacizumab (Anti-VEGF Humanized Monoclonal Antibody) in Previously Untreated Patients with Inflammatory Breast Cancer or Locally Advanced Breast Cancer

* 01-C-0125:
Pilot Study of Non-Myeloablative, HLA-Matched Allogeneic Stem Cell Transplantation for Pediatric Hematopoietic Malignancies

* 01-C-0091:
Phase I Trial and Pharmacokinetic Study of Tariquidar (XR9576), a P-Glycoprotein Inhibitor, in Combination with Doxorubicin, Vinorelbine or Docetaxel in Pediatric Patients with Refractory Solid Tumors Including Brain Tumors

* 01-C-0049:
Phase II Trial of Depsipeptide in Patients with Cutaneous T-Cell Lymphoma and Relapsed Peripheral T-Cell Lymphoma

* 01-C-0037:
Late Effects of Treatment in Survivors of Pediatric Sarcomas

* 01-C-0027:
Natural History of Plexiform in Neurofibromatosis Type I

* 01-C-0009:
Breast Imaging Screening Studies in Women at High Genetic Risk of Breast Cancer: Annual Follow-up Study

* 01-C-0008:
Breast Imaging Studies in Women at High Genetic Risk of Breast Cancer: Menstrual Cycle Pilot Study

* 01-AA-0141:
Polyunsaturated Fatty Acids and the Neurochemistry of Cardiovascular and Behavioral Responses in Aggressive Alcoholics

* 01-AA-0098:
The Effect of Fluoxetine on Measures of Domestic Violence

* 00-N-0140:
A Prospective Natural History Study of VHL Patients with CNS Hemangioblastomas

* 00-N-0057:
Positron Emission Tomography Imaging of Activation-Induced Signal Transduction in Human Brain

* 00-I-0163:
Persistence of Epstein-Barr Virus in Vivo

* 00-I-0143:
Chemokine System Polymorphisms and Risk of Atherosclerosis (CAD)

* 00-I-0071:
Randomized, Open-Label, Phase III, International Study of Recombinant IL-2 (Proleukin) in Pts. w/HIV-1 Infection and CD4 Cell Counts Greater than or Equal to 300 Cells/mm3: Eval of Subcutaneous Proleukin in Randomized International Trial (ESPIRIT)

* 00-HG-0223:
Decisions of Female Adolescents about Carrier Testing in Families with X-Linked Severe Combined Immunodeficiency (XSCID)

* 00-H-0169:
A Phase II Study of Antithymocyte Globulin (ATG) and Cyclosporine to Treat the Cytopenia of Myelodysplastic Syndrome (MDS)

* 00-H-0032:
Treatment of Severe Aplastic Anemia with Combined Immunosuppression: Antithymocyte Globulin (ATG) and Cyclosporine A (CSA), and Mycophenolate Mofetil (MMF)

* 00-DK-0196:
Sirolimus Monotherapy to Optimize Activation Induced Cell Death (AICD) in Renal Transplants Following Lymphocyte Depletion Induction with Thymoglobulin

* 00-DK-0186:
The Hep C Antiviral Long-Term Tx Against Cirrhosis (HALT-C) Trial: A Randomized Controlled Trial to Evaluate the Safety & Efficacy of Long-Term Peginterferon Alpha2A for Tx of Chronic Hep C in Patients Who Failed to Respond to Previous Interferon Therap

* 00-DK-0042:
Pirfenidone in Focal Segmental Glomerulosclerosis:Phase II Study

* 00-CH-0134:
Effects of Metformin on Energy Intake, Energy Expenditure, and Body Weight in Overweight Children with Insulin Resistance

* 00-C-0201:
Active Immunization of Sibling Stem Cell Transplant Donors against Purified Myeloma Protein of the Stem Cell Recipient with Multiple Myeloma in the Setting of Non-Myeloablative, HLA-Matched Allogeneic Peripheral Blood Stem Cell Transplantation

* 00-C-0193:
A Study of the Effects of Potent Anti-HIV Therapy on Parameters Hypothesized to Be Related to the Pathogenesis of Kaposi's Sarcoma (KS) in HIV-Infected Individuals

* 00-C-0133:
Pilot Study of Idiotype Vaccine and EPOCH-Rituximab Chemotherapy in Untreated Mantle Cell Lymphoma

* 00-C-0092:
A Randomized Trial of Filgrastim-SD/01 vs. Filgrastim in Newly Diagnosed Children and Young Adults with Sarcoma Treated with Dose-Intensive Chemotherapy

* 00-C-0080:
A Double Blind Randomized Crossover Phase III Study of Oral Thalidomide versus Placebo in Patients with Stage D0 Androgen Dependent Prostate Cancer Following Limited Hormonal Ablation

* 00-C-0079:
Susceptibility to Breast Cancer

* 00-C-0069:
Phase II Trial of Continuous Hyperthermic Peritoneal Perfusion (CHPP) with Cisplatin plus Early Postoperative Intraperitoneal Paclitaxel and 5-Fluorouracil for Peritoneal Carcinomatosis

* 00-C-0018:
A Pilot Study of Proteomic Evaluation of Epithelial Ovarian Cancer Patients in First Clinical Remission: Development of a Protein Fingerprint Profile Associated with Relapse

* 99-N-0169:
Effect of the Humanized Monoclonal Antibody Against the Interleukin-2 Receptor Alpha Subunit (IL-2R-Alpha; Zenapax® (Registered Trademark)) on Inflammatory Activity in the CNS in MS in a Baseline-to-Treatment, Cross-Over, MRI-Controlled Single Cente

* 99-N-0045:
Study of Abnormal Acquired and Genetic Coagulation Factors in Children with Porencephaly and Stroke

* 99-M-0166:
Investigation of Brain Function During Eyeblink Responding in Normal Volunteers and Patients with Schizophrenia (A Study of Behavior and Evoked Potentials)

* 99-I-0149:
Analysis of the Occurrence of Perilesional Edema and Seizures in Patients with Inactive Cysticercosis

* 99-I-0106:
Trial of Varicella Vaccine for the Prevention of Herpes Zoster and Its Complications

* 99-I-0015:
Immunologic and Virologic Characterization of HIV-Infected Patients After Cessation of Highly Active Antiretroviral Therapy (HAART)

* 99-HG-0056:
Pulmonary Fibrosis Associated with Rheumatoid Arthritis: Definition of the Natural History of Disease

* 99-H-0064:
Exploratory Study of Non-Myeloablative Allogeneic Stem Cell Transplantation and Donor Lymphocyte Infusions for Metastatic Neoplasms Refractory to Standard Therapy

* 99-H-0046:
Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation Followed by T-Cell Add-Back for Hematological Malignancies - Role of Cyclosporine

* 99-DK-0120:
Screening Protocol for Patients Needing a Kidney, Kidney-Pancreas, or Islet Cell Transplant

* 99-DK-0119:
Monitoring for Donor-Specific Hyporesponsiveness Following Renal and Pancreatic Allotransplantation

* 99-DK-0107:
Live Donor Renal Donation for Allotransplantation

* 99-C-0143:
Pilot Study of Donor Th2 Cells for the Prevention of Graft-Versus-Host Disease in the Setting of Non-myeloablative, HLA-matched Allogeneic Peripheral Blood Stem Cell Transplantation

* 99-C-0137:
Vaccine Therapy with Tumor Specific p53 Peptides in Adult Patients with Low Burden Adenocarcinoma of the Ovary

* 99-C-0125:
Osteosarcoma: Outcome of Therapy Based on Histologic Response: A Collaborative Effort of the POB/NCI, Texas Children's Hospital and University of Oklahoma

* 99-C-0088:
(1)H-Nuclear Magnetic Resonance Spectroscopic Imaging of the Brain in Patients who Receive Neurotoxic Therapy

* 99-C-0081:
Methods in Education for Breast Cancer Genetics

* 99-C-0053:
Von Hippel-Lindau Disease Genetic Epidemiology Study

* 98-D-0146:
A Randomized, Placebo-Controlled Trial of Alendronate in the Treatment of Polyostotic Fibrous Dysplasia and the McCune-Albright Syndrome

* 98-CH-0111:
Safety and Efficacy of Orlistat (Xenical, Hoffmann LaRoche) in African American and Caucasian Children and Adolescents with Obesity-Related Comorbid Conditions

* 98-C-0139:
Vaccine Therapy with Tumor Specific Mutated VHL Peptides in Adult Cancer Patients with Renal Cell Carcinoma

* 98-C-0138:
Evaluation of the Association of Polymorphisms in the Innate Immune System with the Risk for Blastomycosis Dermatitidis Infection in Patients not Infected with HIV and Complications Associated with Blastomycosis dermatitidis Infection

* 98-C-0137:
Evaluation of the Association of Polymorphisms in the Innate Immune System with the Risk for Cryptococcus neoformans Infection in Patients not Infected with HIV and Complications Associated with Cryptococcus neoformans Infection

* 98-AR-0124:
Genetics of Rheumatoid Arthritis: The North American Rheumatoid Arthritis Consortium

* 97-M-0126:
Childhood Onset Psychotic Disorders: Characterization and Treatment with Atypical Neuroleptics

* 97-I-0189:
Studies of Lymphocyte Kinetics Using Bromodeoxyuridine

* 97-I-0166:
Polymorphism of the Herpes Simplex Virus Receptor

* 97-I-0082:
Use of Combination Antiviral Therapy to Delineate the Identity and Longevity of Persistent Reservoirs of HIV-1 Infection and Replication

* 97-HG-0173:
Gene Analysis in Parkinson's Disease

* 97-H-0202:
Low Intensity Preparative Regimen Followed by HLA-Matched, Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematologic Malignancies in Older Adults

* 97-H-0154:
High-Dose Cyclophosphamide with CD34+ Selected Autologous Hematopoietic Cell Support for Treatment of Refractory Chronic Autoimmune Thrombocytopenia

* 97-H-0130:
Collection of Blood and Bone Marrow from Healthy Volunteers and Patients for Research Purposes

* 97-H-0117:
A Randomized Trial of Antithymocyte Globulin and Cyclosporine versus Cyclophosphamide and Cyclosporine in the Treatment of Severe Aplastic Anemia

* 97-H-0099:
HLA-Matched Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation Followed by T Cell Add-Back for Hematological Malignancies

* 97-C-0093:
A Pilot Study of 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Pediatric Patients with Primary and Metastatic Brain Tumors

* 97-C-0077:
Vaccination of Follicular Lymphomas with Tumor-Derived Immunoglobulin Idiotype

* 97-C-0052:
A Pilot Study of Autologous T-Cell Transplantation with Vaccine Driven Expansion of Anti-Tumor Effectors after Cytoreductive Therapy in Metastatic Pediatric Sarcomas

* 97-C-0050:
A Pilot Study of Tumor-Specific Peptide Vaccination and IL-2 with or without Autologous T Cell Transplantation in Recurrent Pediatric Sarcomas

* 97-C-0040:
EPOCH Chemotherapy Plus Rituximab for Previously Treated Patients with AIDS-Associated Lymphoma

* 96-CH-0033:
An Open, Randomized, Long-Term Clinical Trial of Flutamide, Testolactone, and Reduced Hydrocortisone Dose vs. Conventional Treatment of Children with Congenital Adrenal Hyperplasia

* 96-C-0133:
Active Specific Immunotherapy for Follicular Lymphomas with Tumor-Derived Immunoglobulin Idiotype Antigen Vaccines

* 96-C-0104:
A Multi-Center Study of Paclitaxel/Cyclophosphamide and High Dose Melphalan/Etoposide with Autologous Progenitor Cell Transplantation for the Treatment of Inflammatory Breast Cancer

* 95-I-0134:
Gene Therapy Approach for Chronic Granulomatous Disease

* 95-I-0072:
Clinical, Virologic, and Immunologic Evaluation and Monitoring of Patients with Known or Suspected HIV Infection

* 95-HG-0158:
Genetic Analysis of Hereditary Prostate Cancer

* 95-H-0167:
Effect of Hypoxia and Smoking on Oxidation of Proteins and Nucleic Acids in Human Volunteers

* 95-CH-0104:
Internal Jugular Vein Sampling for ACTH Levels for the Differential Diagnosis of Cushing Syndrome

* 95-C-0055:
A Multi-Institutional Phase II Study of Cyclophosphamide, Paclitaxel, Cisplatin with G-CSF for Patients with Newly Diagnosed Advanced Stage Ovarian Cancer

* 92-N-0246:
Gene Therapy for the Treatment of Brain Tumors Using Intra-Tumoral Transduction with the Thymidine Kinase Gene and Intravenous Ganciclovir

* 92-DK-0033:
Pharmacokinetics and Biodistribution of Ascorbic Acid in Healthy Human Subjects

* 92-CC-0141:
The Cardiopulmonary Effects of Endotoxin in Normal Human Volunteers

* 90-DK-0137:
Evaluation of the Gastrinoma in Patients with Zollinger-Ellison Syndrome

* 89-I-0174:
Study of Patients with Known or Suspected Infection with Strongyloides Stercoralis

* 86-H-0088:
Lymphocytapheresis of Patients with Pancytopenia

* 85-M-0115:
Biological Markers in Childhood Psychiatric Disorders

* 85-H-0105:
Cardiovascular Evaluation of Homozygous Familial Hypercholesterolemia

* 85-H-0087:
Clinical Course of Patients with Transfusional Hemochromatosis on Deferoxamine

* 84-H-0029:
Effect of Hydroxyurea on Fetal Hemoglobin Synthesis in Patients with Sickle Cell Anemia

* 79-C-0111:
The Treatment of Stage I and II Carcinoma of the Breast with Mastectomy and Axillary Dissection vs. Excisional Biopsy, Axillary Dissection, and Definitive Irradiation

* 76-DK-0081:
Studies with 1,25-Dihydroxycholecalciferol

Command Menu Bar

Search The Studies | Help | Questions |
Clinical Center Home | NIH Home

Clinical Center LogoNational Institutes of Health Clinical Center
Bethesda, Maryland 20892. Last update: 08/12/2009
Search The Studies Help Questions
Search The Studies Help Questions